HLA-DQ	B-protein
tetramers	I-protein
identify	O
epitope-specific	B-cell_type
T	I-cell_type
cells	I-cell_type
in	O
peripheral	O
blood	O
of	O
herpes	O
simplex	O
virus	O
type	O
2-infected	O
individuals	O
:	O
direct	O
detection	O
of	O
immunodominant	B-cell_type
antigen-responsive	I-cell_type
cells	I-cell_type
.	O

Ag-specific	B-cell_type
CD4+	I-cell_type
T	I-cell_type
cells	I-cell_type
are	O
present	O
in	O
peripheral	O
blood	O
in	O
low	O
frequency	O
,	O
where	O
they	O
undergo	O
recruitment	O
and	O
expansion	O
during	O
immune	O
responses	O
and	O
in	O
the	O
pathogenesis	O
of	O
numerous	O
autoimmune	O
diseases	O
.	O

MHC	B-protein
tetramers	I-protein
,	O
which	O
constitute	O
a	O
labeled	B-protein
MHC-peptide	I-protein
ligand	I-protein
suitable	O
for	O
binding	O
to	O
the	O
Ag-specific	B-protein
receptor	I-protein
on	O
T	B-cell_type
cells	I-cell_type
,	O
provide	O
a	O
novel	O
approach	O
for	O
the	O
detection	O
and	O
characterization	O
of	O
such	O
rare	B-cell_type
cells	I-cell_type
.	O

In	O
this	O
study	O
,	O
we	O
utilized	O
this	O
technology	O
to	O
identify	O
HLA	B-protein
DQ	I-protein
-restricted	O
Ag-specific	B-cell_type
T	I-cell_type
cells	I-cell_type
in	O
the	O
peripheral	O
blood	O
of	O
human	O
subjects	O
and	O
to	O
identify	O
immunodominant	O
epitopes	O
associated	O
with	O
viral	O
infection	O
.	O

Peptides	O
representing	O
potential	O
epitope	B-protein
regions	I-protein
of	O
the	O
VP16	B-protein
protein	I-protein
from	O
HSV-2	O
were	O
loaded	O
onto	O
recombinant	B-protein
DQ0602	I-protein
molecules	I-protein
to	O
generate	O
a	O
panel	O
of	O
Ag-specific	B-protein
DQ0602	I-protein
tetramers	I-protein
.	O

VP16	B-protein
Ag	I-protein
-specific	O
DQ-restricted	B-cell_type
T	I-cell_type
cells	I-cell_type
were	O
identified	O
and	O
expanded	O
from	O
the	O
peripheral	O
blood	O
of	O
HSV-2-infected	O
individuals	O
,	O
representing	O
two	O
predominant	O
epitope	O
specificities	O
.	O

Although	O
the	O
VP16	O
369-380	O
peptide	O
has	O
a	O
lower	O
binding	O
affinity	O
for	O
DQ0602	B-protein
molecules	I-protein
than	O
the	O
VP16	O
33-52	O
peptide	O
,	O
T	B-cell_type
cells	I-cell_type
that	O
recognized	O
the	O
VP16	O
369-380	O
peptide	O
occurred	O
at	O
a	O
much	O
higher	O
frequency	O
than	O
those	O
that	O
were	O
specific	O
for	O
the	O
VP16	O
33-52	O
peptide	O
.	O

Accelerating	NULL
Life	NULL
Sciences	NULL
.	NULL

2	NULL
nozzles	NULL
per	NULL
well	NULL
enable	NULL
cell	NULL
A	NULL
Check	NULL
out	NULL
how	NULL
Laminar	NULL
Wash	NULL
l	NULL
washing	NULL
by	NULL
creating	NULL
a	NULL
laminar	NULL
I	NULL
“	NULL
CU	NULL
RIOX	NULL
systems	NULL
replace	NULL
centrifugation	NULL
completely	NULL
in	NULL
handling	NULL
cells	NULL
See	NULL
How	NULL
It	NULL
Works	NULL
Ka	NULL
me	NULL
Journal	NULL
o	NULL
HLA-DQ	NULL
Tetlzamers	NULL
Identify	NULL
Epitope-Specific	NULL
U*	NULL
Imnmunolo	NULL
gy	NULL
T	NULL
Cells	NULL
in	NULL
Peripheral	NULL
Blood	NULL
of	NULL
Herpes	NULL
Simplex	NULL
Virus	NULL
Type	NULL
2-Infected	NULL
Individuals	NULL
:	NULL
Direct	NULL
Detection	NULL
of	NULL
Immunodominant	NULL
This	NULL
information	NULL
is	NULL
current	NULL
as	NULL
Antigen_ReSp0nSive	NULL
Cells	NULL
of	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

William	NULL
W.	NULL
Kwok	NULL
,	NULL
Andrew	NULL
W.	NULL
Liu	NULL
,	NULL
Erik	NULL
J.	NULL
Novak	NULL
,	NULL
John	NULL
A.	NULL
Gebe	NULL
,	NULL
Ruth	NULL
A.	NULL
Ettinger	NULL
,	NULL
Gerald	NULL
T.	NULL
Nepom	NULL
,	NULL
Sigrid	NULL
N.	NULL
Reymond	NULL
and	NULL
David	NULL
M.	NULL
Koelle	NULL
J	NULL
Immunol	NULL
2000	NULL
;	NULL
164:4244-4249	NULL
;	NULL
;	NULL
doi	NULL
:	NULL
10.4049/jimmunol.164.8.4244	NULL
http	NULL
:	NULL
//www	NULL
.jimmunol.org/content/164/8/4244	NULL
References	NULL
_	NULL
This	NULL
article	NULL
cites	NULL
23	NULL
articles	NULL
,	NULL
13	NULL
of	NULL
which	NULL
you	NULL
can	NULL
access	NULL
for	NULL
free	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www	NULL
.jimmunol.org/content/164/8/4244	NULL
.	NULL

full	NULL
#	NULL
ref-list-1	NULL
Why	NULL
The	NULL
JT	NULL
?	NULL

Submit	NULL
online	NULL
.	NULL

«	NULL
Rapid	NULL
Reviews	NULL
!	NULL

30	NULL
days*	NULL
from	NULL
submission	NULL
to	NULL
initial	NULL
decision	NULL
*	NULL
No	NULL
Triage	NULL
!	NULL

Every	NULL
submission	NULL
reviewed	NULL
by	NULL
practicing	NULL
scientists	NULL
*	NULL
Fast	NULL
Publication	NULL
!	NULL

4	NULL
weeks	NULL
from	NULL
acceptance	NULL
to	NULL
publication	NULL
*average	NULL
Subscription	NULL
_-	NULL
Information	NULL
about	NULL
subscribing	NULL
to	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
is	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//jimmunol.org/subscription	NULL
Permissions	NULL
_	NULL
Submit	NULL
copyright	NULL
permission	NULL
requests	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.aai.org/About/Publications/Jl/copyright.html	NULL
Email	NULL
Alerts	NULL
_	NULL
Receive	NULL
free	NULL
email-alerts	NULL
when	NULL
new	NULL
articles	NULL
cite	NULL
this	NULL
article	NULL
.	NULL

Sign	NULL
up	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//jimmunol.org/alerts	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
is	NULL
published	NULL
twice	NULL
each	NULL
month	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
,	NULL
Inc.	NULL
,	NULL
1451	NULL
Rockville	NULL
Pike	NULL
,	NULL
Suite	NULL
650	NULL
,	NULL
Rockville	NULL
,	NULL
MD	NULL
20852	NULL
Copyright	NULL
©	NULL
2000	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
All	NULL
rights	NULL
reserved	NULL
.	NULL

Print	NULL
ISSN	NULL
:	NULL
0022-1767	NULL
Online	NULL
ISSN	NULL
:	NULL
1550-6606	NULL
.	NULL

6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
HLA-DQ	NULL
Tetramers	NULL
Identify	NULL
Epitope-Specific	NULL
T	NULL
Cells	NULL
in	NULL
Peripheral	NULL
Blood	NULL
of	NULL
Herpes	NULL
Simplex	NULL
Virus	NULL
Type	NULL
2-Infected	NULL
Individuals	NULL
:	NULL
Direct	NULL
Detection	NULL
of	NULL
Immunodominant	NULL
Antigen-Responsive	NULL
Cells	NULL
William	NULL
W.	NULL
Kwok	NULL
,	NULL
``	NULL
*	NULL
Andrew	NULL
W.	NULL
Liu	NULL
,	NULL
*	NULL
Erik	NULL
J.	NULL
Novak	NULL
,	NULL
*	NULL
``	NULL
John	NULL
A.	NULL
Gebe	NULL
,	NULL
*	NULL
Ruth	NULL
A.	NULL
Ettinger	NULL
,	NULL
*	NULL
Gerald	NULL
T.	NULL
Nepom	NULL
,	NULL
**	NULL
Sigrid	NULL
N.	NULL
Reymond	NULL
,	NULL
``	NULL
and	NULL
David	NULL
M.	NULL
Koelle*	NULL
Ag-specific	NULL
CD4	NULL
*	NULL
T	NULL
cells	NULL
are	NULL
present	NULL
in	NULL
peripheral	NULL
blood	NULL
in	NULL
low	NULL
frequency	NULL
,	NULL
where	NULL
they	NULL
undergo	NULL
recruitment	NULL
and	NULL
expansion	NULL
during	NULL
immune	NULL
responses	NULL
and	NULL
in	NULL
the	NULL
pathogenesis	NULL
of	NULL
numerous	NULL
autoimmune	NULL
diseases	NULL
.	NULL

MHC	NULL
tetramers	NULL
,	NULL
which	NULL
constitute	NULL
a	NULL
labeled	NULL
MHC-peptide	NULL
ligand	NULL
suitable	NULL
for	NULL
binding	NULL
to	NULL
the	NULL
Ag-specific	NULL
receptor	NULL
on	NULL
T	NULL
cells	NULL
,	NULL
provide	NULL
a	NULL
novel	NULL
approach	NULL
for	NULL
the	NULL
detection	NULL
and	NULL
characterization	NULL
of	NULL
such	NULL
rare	NULL
cells	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
we	NULL
utilized	NULL
this	NULL
technology	NULL
to	NULL
identify	NULL
HLA	NULL
DQ-restricted	NULL
Ag-specific	NULL
T	NULL
cells	NULL
in	NULL
the	NULL
peripheral	NULL
blood	NULL
of	NULL
human	NULL
subjects	NULL
and	NULL
to	NULL
identify	NULL
immunodominant	NULL
epitopes	NULL
associated	NULL
with	NULL
viral	NULL
infection	NULL
.	NULL

Peptides	NULL
representing	NULL
potential	NULL
epitope	NULL
regions	NULL
of	NULL
the	NULL
VP16	NULL
protein	NULL
from	NULL
HSV-2	NULL
were	NULL
loaded	NULL
onto	NULL
recombinant	NULL
DQ0602	NULL
molecules	NULL
to	NULL
generate	NULL
a	NULL
panel	NULL
of	NULL
Ag-specific	NULL
DQ0602	NULL
tetramers	NULL
.	NULL

VP16	NULL
Ag-specific	NULL
DQ-restricted	NULL
T	NULL
cells	NULL
were	NULL
identified	NULL
and	NULL
expanded	NULL
from	NULL
the	NULL
peripheral	NULL
blood	NULL
of	NULL
HSV-2-infected	NULL
individuals	NULL
,	NULL
representing	NULL
two	NULL
predominant	NULL
epitope	NULL
specificities	NULL
.	NULL

Although	NULL
the	NULL
VP16	NULL
369-380	NULL
peptide	NULL
has	NULL
a	NULL
lower	NULL
binding	NULL
affinity	NULL
for	NULL
DQ0602	NULL
molecules	NULL
than	NULL
the	NULL
VP16	NULL
33-52	NULL
peptide	NULL
,	NULL
T	NULL
cells	NULL
that	NULL
recognized	NULL
the	NULL
VP16	NULL
369-380	NULL
peptide	NULL
occurred	NULL
at	NULL
a	NULL
much	NULL
higher	NULL
frequency	NULL
than	NULL
those	NULL
that	NULL
were	NULL
specific	NULL
for	NULL
the	NULL
VP16	NULL
33-52	NULL
peptide	NULL
.	NULL

The	NULL
Journal	NULL
of	NULL
Immunology	NULL
,	NULL
2000	NULL
,	NULL
164	NULL
:	NULL
4244-4249.	NULL
striction	NULL
elements	NULL
for	NULL
presentation	NULL
of	NULL
antigenic	NULL
peptides	NULL
to	NULL
human	NULL
CD4	NULL
*	NULL
T	NULL
cells	NULL
.	NULL

Techniques	NULL
of	NULL
T	NULL
cell	NULL
cloning	NULL
and	NULL
limiting	NULL
dilution	NULL
assays	NULL
have	NULL
been	NULL
successfully	NULL
applied	NULL
to	NULL
the	NULL
detection	NULL
and	NULL
isolation	NULL
of	NULL
peripheral	NULL
blood	NULL
T	NULL
cells	NULL
that	NULL
are	NULL
restricted	NULL
by	NULL
HLA-DR	NULL
molecules	NULL
.	NULL

T	NULL
cells	NULL
that	NULL
are	NULL
restricted	NULL
by	NULL
DQ	NULL
and	NULL
DP	NULL
molecules	NULL
generally	NULL
occur	NULL
at	NULL
a	NULL
lower	NULL
frequency	NULL
than	NULL
those	NULL
restricted	NULL
by	NULL
DR	NULL
and	NULL
are	NULL
less	NULL
well	NULL
characterized	NULL
.	NULL

DQ-restricted	NULL
T	NULL
cells	NULL
are	NULL
of	NULL
special	NULL
interest	NULL
in	NULL
that	NULL
autoimmune	NULL
diseases	NULL
including	NULL
insulin-dependent	NULL
diabetes	NULL
mellitus	NULL
,	NULL
celiac	NULL
disease	NULL
,	NULL
and	NULL
pemphigus	NULL
vulgaris	NULL
are	NULL
associated	NULL
with	NULL
specific	NULL
HLA-DQ	NULL
alleles	NULL
(	NULL
1-4	NULL
)	NULL
.	NULL

Recently	NULL
,	NULL
MHC	NULL
tetramer	NULL
technology	NULL
has	NULL
been	NULL
developed	NULL
to	NULL
detect	NULL
T	NULL
cells	NULL
.	NULL

This	NULL
technology	NULL
utilizes	NULL
specific	NULL
,	NULL
labeled	NULL
MHC-pep-tide	NULL
complexes	NULL
to	NULL
detect	NULL
Ag-specific	NULL
T	NULL
cells	NULL
by	NULL
direct	NULL
binding	NULL
of	NULL
the	NULL
TCR	NULL
complex	NULL
,	NULL
with	NULL
visualization	NULL
by	NULL
fluorescence	NULL
flow	NULL
cytometry	NULL
.	NULL

This	NULL
has	NULL
been	NULL
successful	NULL
in	NULL
a	NULL
variety	NULL
of	NULL
studies	NULL
focused	NULL
on	NULL
the	NULL
identification	NULL
of	NULL
CD8	NULL
*	NULL
class	NULL
L-restricted	NULL
T	NULL
cells	NULL
(	NULL
5-10	NULL
)	NULL
,	NULL
whereas	NULL
analysis	NULL
of	NULL
CD4	NULL
*	NULL
class	NULL
II-restricted	NULL
T	NULL
cells	NULL
has	NULL
been	NULL
much	NULL
more	NULL
elusive	NULL
.	NULL

Most	NULL
class	NULL
II	NULL
MHC	NULL
tetramers	NULL
studies	NULL
are	NULL
limited	NULL
to	NULL
murine	NULL
class	NULL
II	NULL
molecules	NULL
(	NULL
11-13	NULL
)	NULL
.	NULL

Recently	NULL
,	NULL
we	NULL
utilized	NULL
DR	NULL
tetramers	NULL
to	NULL
T	NULL
he	NULL
HLA	NULL
class	NULL
II	NULL
molecules	NULL
,	NULL
DR	NULL
,	NULL
DQ	NULL
,	NULL
and	NULL
DP	NULL
,	NULL
act	NULL
as	NULL
re	NULL
*Virginia	NULL
Mason	NULL
Research	NULL
Center	NULL
,	NULL
Seattle	NULL
,	NULL
WA	NULL
98101	NULL
;	NULL
'	NULL
R	NULL
.	NULL

H.	NULL
Williams	NULL
Laboratory	NULL
and	NULL
Molecular	NULL
and	NULL
Cellular	NULL
Biology	NULL
Program	NULL
and	NULL
*Department	NULL
of	NULL
Immunology	NULL
,	NULL
University	NULL
of	NULL
Washington	NULL
,	NULL
Seattle	NULL
,	NULL
WA	NULL
98195	NULL
;	NULL
and	NULL
Virology	NULL
Division	NULL
,	NULL
Harborview	NULL
Medical	NULL
Center	NULL
,	NULL
Seattle	NULL
,	NULL
WA	NULL
98104	NULL
Received	NULL
for	NULL
publication	NULL
December	NULL
27	NULL
,	NULL
1999	NULL
.	NULL

Accepted	NULL
for	NULL
publication	NULL
February	NULL
9	NULL
,	NULL
2000	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
adverfisement	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL
'	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
Grants	NULL
AI44443	NULL
and	NULL
DK02319	NULL
(	NULL
W.W.K	NULL
.	NULL
)	NULL

,	NULL
DK49841	NULL
(	NULL
G.T.N	NULL
.	NULL
)	NULL

,	NULL
and	NULL
AI30717	NULL
and	NULL
CA70017	NULL
(	NULL
D.M.K	NULL
.	NULL
)	NULL

.	NULL

?	NULL

Address	NULL
correspondence	NULL
and	NULL
reprint	NULL
requests	NULL
to	NULL
Dr.	NULL
William	NULL
Kwok	NULL
,	NULL
Virginia	NULL
Mason	NULL
Research	NULL
Center	NULL
,	NULL
1201	NULL
Ninth	NULL
Avenue	NULL
,	NULL
Seattle	NULL
WA	NULL
98101-2795	NULL
.	NULL

E-mail	NULL
address	NULL
:	NULL
bkwok	NULL
@	NULL
vmresearch.org	NULL
Copyright	NULL
©	NULL
2000	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
analyze	NULL
human	NULL
DR-restricted	NULL
T	NULL
cell	NULL
responses	NULL
to	NULL
influenza	NULL
A	NULL
(	NULL
14	NULL
)	NULL
.	NULL

The	NULL
low	NULL
frequency	NULL
of	NULL
Ag-specific	NULL
peripheral	NULL
T	NULL
cells	NULL
in	NULL
humans	NULL
and	NULL
concerns	NULL
related	NULL
to	NULL
the	NULL
stability	NULL
of	NULL
soluble	NULL
class	NULL
II	NULL
molecules	NULL
have	NULL
challenged	NULL
the	NULL
development	NULL
of	NULL
this	NULL
technology	NULL
,	NULL
particularly	NULL
with	NULL
HLA-DQ	NULL
molecules	NULL
,	NULL
in	NULL
which	NULL
the	NULL
molecules	NULL
are	NULL
unstable	NULL
compared	NULL
with	NULL
HLA-DR	NULL
(	NULL
15	NULL
,	NULL
16	NULL
)	NULL
.	NULL

We	NULL
now	NULL
report	NULL
the	NULL
development	NULL
of	NULL
class	NULL
II	NULL
peptide-tetramers	NULL
that	NULL
detect	NULL
human	NULL
peripheral	NULL
blood	NULL
T	NULL
cells	NULL
restricted	NULL
by	NULL
HLA-DQ	NULL
molecules	NULL
in	NULL
Ag-specific	NULL
immune	NULL
responses	NULL
to	NULL
HSV-2	NULL
.	NULL

Materials	NULL
and	NULL
Methods	NULL
Patient	NULL
population	NULL
Patients	NULL
were	NULL
HSV-2-infected	NULL
individuals	NULL
who	NULL
visit	NULL
the	NULL
outpatient	NULL
sexually	NULL
transmitted	NULL
disease	NULL
clinics	NULL
of	NULL
the	NULL
University	NULL
of	NULL
Washington	NULL
Medical	NULL
Cen-ter	NULL
.	NULL

HSV-2	NULL
infection	NULL
was	NULL
confirmed	NULL
by	NULL
HSV	NULL
type-specific	NULL
immunoblot	NULL
(	NULL
17	NULL
)	NULL
.	NULL

All	NULL
patients	NULL
were	NULL
asymptomatic	NULL
when	NULL
their	NULL
PBMC	NULL
were	NULL
obtained	NULL
for	NULL
these	NULL
studies	NULL
.	NULL

HLA-DR	NULL
and	NULL
DQ	NULL
typing	NULL
were	NULL
performed	NULL
by	NULL
reverse	NULL
dot	NULL
blot	NULL
hybridization	NULL
(	NULL
18	NULL
)	NULL
.	NULL

Isolation	NULL
and	NULL
characterization	NULL
of	NULL
DQO6O02-restricted	NULL
T	NULL
cells	NULL
PBMC	NULL
from	NULL
HSV-2-seropositive	NULL
individual	NULL
5491	NULL
(	NULL
HLA-DRB1*1501	NULL
,	NULL
*0301	NULL
and	NULL
DQB1*0602	NULL
,	NULL
©0201	NULL
)	NULL
were	NULL
plated	NULL
at	NULL
2	NULL
X	NULL
10°	NULL
cells/well	NULL
in	NULL
a	NULL
24-well	NULL
plate	NULL
in	NULL
medium	NULL
consisting	NULL
of	NULL
RPMI	NULL
and	NULL
15	NULL
%	NULL
heat-inactivated	NULL
pooled	NULL
human	NULL
serum	NULL
.	NULL

Cells	NULL
were	NULL
stimulated	NULL
with	NULL
VP16	NULL
protein	NULL
(	NULL
gift	NULL
from	NULL
Chiron	NULL
,	NULL
Emeryville	NULL
CA	NULL
)	NULL
at	NULL
2	NULL
ug/ml	NULL
.	NULL

Starting	NULL
on	NULL
day	NULL
5	NULL
,	NULL
cells	NULL
were	NULL
fed	NULL
every	NULL
other	NULL
day	NULL
with	NULL
fresh	NULL
medium	NULL
and	NULL
IL-2	NULL
(	NULL
Hemagen	NULL
,	NULL
Worcester	NULL
MA	NULL
)	NULL
at	NULL
a	NULL
concentration	NULL
of	NULL
16	NULL
U/ml	NULL
.	NULL

On	NULL
day	NULL
12	NULL
,	NULL
cells	NULL
were	NULL
washed	NULL
and	NULL
plated	NULL
at	NULL
1	NULL
cell/well	NULL
in	NULL
a	NULL
96-well	NULL
U-bottom	NULL
plate	NULL
which	NULL
also	NULL
contained	NULL
1.5	NULL
X	NULL
10°	NULL
irradiated	NULL
(	NULL
3300	NULL
rad	NULL
)	NULL
autologous	NULL
PBMC	NULL
and	NULL
0.8	NULL
pg/ml	NULL
PHA	NULL
.	NULL

IL-2	NULL
was	NULL
added	NULL
48	NULL
h	NULL
later	NULL
.	NULL

At	NULL
day	NULL
26	NULL
,	NULL
cells	NULL
from	NULL
each	NULL
positive	NULL
well	NULL
were	NULL
evaluated	NULL
for	NULL
Ag-specific	NULL
proliferation	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
2	NULL
ug/ml	NULL
VP16	NULL
and	NULL
L-243	NULL
(	NULL
anti-DR	NULL
)	NULL
or	NULL
SPVL-3	NULL
(	NULL
anti-DQ	NULL
)	NULL
at	NULL
5	NULL
ug/ml	NULL
,	NULL
with	NULL
1	NULL
X	NULL
10°	NULL
irradiated	NULL
PBMC	NULL
from	NULL
an	NULL
HLA	NULL
haplotype-matched	NULL
individual	NULL
as	NULL
APC	NULL
(	NULL
HLA-DRB1*0101	NULL
,	NULL
*1501	NULL
and	NULL
DQB1*0501	NULL
,	NULL
#	NULL
0602	NULL
)	NULL
.	NULL

After	NULL
48	NULL
h	NULL
,	NULL
(	NULL
1	NULL
was	NULL
added	NULL
for	NULL
16	NULL
h	NULL
,	NULL
and	NULL
cells	NULL
were	NULL
then	NULL
harvested	NULL
and	NULL
counted	NULL
.	NULL

Cells	NULL
that	NULL
proliferated	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
L-243	NULL
and	NULL
that	NULL
were	NULL
inhibited	NULL
by	NULL
SPVL-3	NULL
were	NULL
selected	NULL
for	NULL
epitope	NULL
specificity	NULL
.	NULL

0022-1767/00/	NULL
$	NULL
02.00	NULL
6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
For	NULL
epitope	NULL
studies	NULL
,	NULL
a	NULL
panel	NULL
of	NULL
60	NULL
peptides	NULL
was	NULL
used	NULL
,	NULL
each	NULL
20	NULL
aa	NULL
long	NULL
,	NULL
which	NULL
corresponded	NULL
to	NULL
the	NULL
entire	NULL
VP16	NULL
protein	NULL
with	NULL
a	NULL
12-aa	NULL
overlap	NULL
between	NULL
adjacent	NULL
peptides	NULL
.	NULL

The	NULL
peptides	NULL
were	NULL
synthesized	NULL
by	NULL
Multipin	NULL
peptide	NULL
technology	NULL
(	NULL
Chiron	NULL
Technologies	NULL
,	NULL
Clayton	NULL
,	NULL
Australia	NULL
)	NULL
.	NULL

For	NULL
the	NULL
proliferation	NULL
assays	NULL
,	NULL
triplicate	NULL
wells	NULL
contained	NULL
10*	NULL
T	NULL
cells	NULL
,	NULL
10°	NULL
irradiated	NULL
PBMC	NULL
(	NULL
DRB1*0101/1501	NULL
,	NULL
DQB1*0501/0602	NULL
)	NULL
,	NULL
and	NULL
1	NULL
M	NULL
peptide	NULL
in	NULL
200	NULL
ul	NULL
T	NULL
cell	NULL
medium	NULL
in	NULL
96-well	NULL
U-bottom	NULL
plates	NULL
.	NULL

After	NULL
48	NULL
h	NULL
,	NULL
1	NULL
Ci	NULL
[	NULL
°H	NULL
]	NULL
thymidine	NULL
was	NULL
added	NULL
,	NULL
and	NULL
the	NULL
cells	NULL
were	NULL
harvested	NULL
and	NULL
counted	NULL
after	NULL
an	NULL
additional	NULL
16	NULL
h.	NULL
Construction	NULL
of	NULL
DQO6O2-leucine	NULL
zipper-biotinylation	NULL
site	NULL
expression	NULL
vectors	NULL
Chimeric	NULL
cassettes	NULL
containing	NULL
the	NULL
coding	NULL
regions	NULL
for	NULL
the	NULL
HLA-DQ	NULL
extra-cellular	NULL
domain/leucine	NULL
zipper	NULL
(	NULL
LZ	NULL
)	NULL
®	NULL
molecules	NULL
were	NULL
made	NULL
using	NULL
a	NULL
PCR-mediated	NULL
splicing	NULL
overlap	NULL
extension	NULL
technique	NULL
(	NULL
19	NULL
)	NULL
.	NULL

Plasmids	NULL
pN15LZa	NULL
and	NULL
pLN15LZf	NULL
were	NULL
gifts	NULL
from	NULL
Dr.	NULL
D.	NULL
Ostrov	NULL
and	NULL
Dr.	NULL
S.	NULL
Nathenson	NULL
,	NULL
Mt	NULL
.	NULL

Sinai	NULL
Medical	NULL
School	NULL
(	NULL
New	NULL
York	NULL
,	NULL
NY	NULL
)	NULL
.	NULL

For	NULL
generation	NULL
of	NULL
the	NULL
soluble	NULL
DQA1	NULL
chain	NULL
,	NULL
cDNA	NULL
of	NULL
DQA1*0102	NULL
was	NULL
amplified	NULL
in	NULL
the	NULL
first	NULL
round	NULL
using	NULL
the	NULL
primer	NULL
pair	NULL
,	NULL
(	NULL
+	NULL
)	NULL
5-GGAATTCATGATCCTAAACAAAGCTCT-3	NULL
'	NULL
and	NULL
(	NULL
-	NULL
)	NULL
5'-CCAGGTCTGCTGACGACTCTGTGAGCTCTGACATAG-3	NULL
'	NULL
(	NULL
sharing	NULL
homology	NULL
with	NULL
the	NULL
5	NULL
'	NULL
end	NULL
of	NULL
basic	NULL
LZ	NULL
)	NULL
at	NULL
a	NULL
concentration	NULL
of	NULL
4	NULL
nM	NULL
for	NULL
each	NULL
primer	NULL
.	NULL

For	NULL
the	NULL
second	NULL
round	NULL
amplification	NULL
,	NULL
the	NULL
first	NULL
round	NULL
product	NULL
was	NULL
used	NULL
as	NULL
the	NULL
initial	NULL
(	NULL
+	NULL
)	NULL
primer	NULL
on	NULL
the	NULL
pN15LZa	NULL
template	NULL
containing	NULL
the	NULL
basic	NULL
LZ	NULL
cDNA	NULL
motif	NULL
at	NULL
a	NULL
concentration	NULL
of	NULL
10	NULL
pM	NULL
to	NULL
form	NULL
a	NULL
DQA1*0102/LZ	NULL
chimera	NULL
.	NULL

The	NULL
primer	NULL
pair	NULL
,	NULL
(	NULL
+	NULL
)	NULL
5'-GGAATTCATGATCCTAAACAAAGCTCT-3	NULL
'	NULL
and	NULL
(	NULL
=	NULL
)	NULL
5'-CTGGTACCATCCTACTGGGCGAGTT-3	NULL
'	NULL
(	NULL
sharing	NULL
homology	NULL
with	NULL
the	NULL
3	NULL
'	NULL
end	NULL
of	NULL
LZ	NULL
)	NULL
,	NULL
was	NULL
then	NULL
used	NULL
to	NULL
amplify	NULL
the	NULL
chimera	NULL
.	NULL

The	NULL
fragment	NULL
was	NULL
TA	NULL
cloned	NULL
into	NULL
pCR2.1Topo	NULL
(	NULL
Invitrogen	NULL
,	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
)	NULL
sequenced	NULL
and	NULL
then	NULL
subcloned	NULL
into	NULL
the	NULL
metal	NULL
inducible	NULL
Drosophila	NULL
expression	NULL
vector	NULL
pRmHa-3	NULL
(	NULL
gift	NULL
from	NULL
Dr.	NULL
L.	NULL
S.	NULL
B.	NULL
Goldstein	NULL
,	NULL
Howard	NULL
Hughes	NULL
Medical	NULL
Institute	NULL
,	NULL
La	NULL
Jolla	NULL
,	NULL
CA	NULL
)	NULL
using	NULL
EcoRI	NULL
and	NULL
KpnI	NULL
sites	NULL
engineered	NULL
into	NULL
the	NULL
second	NULL
round	NULL
primer	NULL
pair	NULL
(	NULL
underlined	NULL
above	NULL
)	NULL
.	NULL

For	NULL
generation	NULL
of	NULL
the	NULL
soluble	NULL
DQB1	NULL
chain	NULL
,	NULL
cDNA	NULL
of	NULL
DQB1*0602	NULL
was	NULL
initially	NULL
amplified	NULL
using	NULL
the	NULL
primer	NULL
pair	NULL
,	NULL
(	NULL
+	NULL
)	NULL
5'-ACCTCGAGGTCT	NULL
CAATTATGTC-3	NULL
'	NULL
and	NULL
(	NULL
-	NULL
)	NULL
GGCAGA-3	NULL
'	NULL
(	NULL
sharing	NULL
homology	NULL
with	NULL
the	NULL
5	NULL
'	NULL
end	NULL
of	NULL
acidic	NULL
LZ	NULL
)	NULL
at	NULL
a	NULL
concentration	NULL
of	NULL
4	NULL
nM	NULL
.	NULL

For	NULL
the	NULL
second	NULL
round	NULL
amplification	NULL
,	NULL
the	NULL
first	NULL
round	NULL
product	NULL
was	NULL
used	NULL
as	NULL
the	NULL
initial	NULL
(	NULL
+	NULL
)	NULL
primer	NULL
on	NULL
the	NULL
pN15LZB	NULL
template	NULL
containing	NULL
the	NULL
acidic	NULL
LZ	NULL
cDNA	NULL
motif	NULL
at	NULL
a	NULL
concentration	NULL
of	NULL
10	NULL
pM	NULL
to	NULL
form	NULL
a	NULL
DQB1*0602/LZ	NULL
chimera	NULL
.	NULL

The	NULL
primer	NULL
pair	NULL
,	NULL
(	NULL
+	NULL
)	NULL
5'-	NULL
ACCTCGAGGTCT	NULL
CAATTATGTC-3	NULL
'	NULL
and	NULL
(	NULL
-	NULL
)	NULL
5'-ACAAGCTTCCCTGAGCCAGTTCC	NULL
TTTTCC-3	NULL
'	NULL
(	NULL
sharing	NULL
homology	NULL
with	NULL
the	NULL
3	NULL
'	NULL
end	NULL
of	NULL
the	NULL
acidic	NULL
LZ	NULL
)	NULL
,	NULL
was	NULL
then	NULL
used	NULL
to	NULL
amplify	NULL
the	NULL
chimera	NULL
.	NULL

This	NULL
DQ	NULL
cassette	NULL
was	NULL
then	NULL
cloned	NULL
into	NULL
vector	NULL
pAC1	NULL
(	NULL
Avidity	NULL
,	NULL
Denver	NULL
,	NULL
CO	NULL
)	NULL
,	NULL
using	NULL
the	NULL
XhoI	NULL
and	NULL
HindIII	NULL
sites	NULL
(	NULL
underlined	NULL
above	NULL
)	NULL
,	NULL
5	NULL
'	NULL
of	NULL
the	NULL
biotinylation	NULL
sequence	NULL
;	NULL
the	NULL
complete	NULL
DQB1*0602-LZ	NULL
biotinylation	NULL
site	NULL
cassette	NULL
was	NULL
then	NULL
recovered	NULL
by	NULL
PCR	NULL
amplification	NULL
with	NULL
the	NULL
primer	NULL
pair	NULL
,	NULL
(	NULL
+	NULL
)	NULL
5-AGAATTCGTCTCAATTATGTCTTGGAA-3	NULL
'	NULL
and	NULL
5'-CTGGTACCTTAGTGCCATTCGATTTTCTG-3	NULL
'	NULL
,	NULL
and	NULL
TA	NULL
was	NULL
cloned	NULL
into	NULL
pCR2.1Topo	NULL
,	NULL
sequenced	NULL
,	NULL
and	NULL
then	NULL
subcloned	NULL
into	NULL
the	NULL
Drosophila	NULL
expression	NULL
vector	NULL
pRmHa-3	NULL
using	NULL
EcoRI	NULL
and	NULL
KprI	NULL
(	NULL
sites	NULL
underlined	NULL
)	NULL
.	NULL

Generation	NULL
of	NULL
DQO6O2	NULL
tetramers	NULL
The	NULL
DQA1	NULL
and	NULL
DQB1	NULL
chimeric	NULL
cDNAs	NULL
in	NULL
the	NULL
Schneider	NULL
expression	NULL
vector	NULL
pRmHa-3	NULL
were	NULL
cotransfected	NULL
with	NULL
the	NULL
phshsneo	NULL
plasmid	NULL
(	NULL
gift	NULL
from	NULL
Dr.	NULL
M.	NULL
McKeown	NULL
,	NULL
Salk	NULL
Institute	NULL
,	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
)	NULL
into	NULL
S-2	NULL
Schneider	NULL
cells	NULL
(	NULL
gift	NULL
from	NULL
Dr.	NULL
D.	NULL
Zaller	NULL
,	NULL
Merck	NULL
Research	NULL
Laboratories	NULL
,	NULL
Rahway	NULL
,	NULL
NJ	NULL
)	NULL
by	NULL
standard	NULL
calcium	NULL
phosphate	NULL
transfection	NULL
techniques	NULL
.	NULL

Cells	NULL
were	NULL
selected	NULL
with	NULL
G418	NULL
at	NULL
2	NULL
mg/ml	NULL
(	NULL
Life	NULL
Technologies	NULL
,	NULL
Gaithersburg	NULL
,	NULL
MD	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
expanded	NULL
and	NULL
were	NULL
grown	NULL
to	NULL
a	NULL
density	NULL
of	NULL
1	NULL
X	NULL
10	NULL
``	NULL
cells/ml	NULL
.	NULL

CuSO	NULL
,	NULL
was	NULL
added	NULL
to	NULL
a	NULL
concentration	NULL
of	NULL
1	NULL
mM	NULL
to	NULL
induce	NULL
the	NULL
production	NULL
of	NULL
class	NULL
II	NULL
molecules	NULL
.	NULL

The	NULL
DQ0602	NULL
molecules	NULL
from	NULL
the	NULL
supernatant	NULL
were	NULL
purified	NULL
by	NULL
affinity	NULL
chroma-tography	NULL
using	NULL
SPVL-3	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
20	NULL
)	NULL
.	NULL

The	NULL
class	NULL
II	NULL
molecules	NULL
were	NULL
concentrated	NULL
to	NULL
1-2	NULL
mg/ml	NULL
and	NULL
then	NULL
dia-lyzed	NULL
in	NULL
10	NULL
mM	NULL
Tris	NULL
(	NULL
pH	NULL
8	NULL
)	NULL
,	NULL
10	NULL
mM	NULL
NaCl	NULL
.	NULL

The	NULL
protein	NULL
was	NULL
then	NULL
biotinylated	NULL
by	NULL
using	NULL
the	NULL
Bir	NULL
A	NULL
enzyme	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
conditions	NULL
(	NULL
Avidity	NULL
,	NULL
Denver	NULL
,	NULL
CO	NULL
)	NULL
.	NULL

The	NULL
excess	NULL
biotin	NULL
was	NULL
removed	NULL
by	NULL
dialysis	NULL
.	NULL

The	NULL
biotinylated	NULL
DQ0602	NULL
molecules	NULL
were	NULL
then	NULL
loaded	NULL
with	NULL
the	NULL
appropriate	NULL
peptides	NULL
at	NULL
a	NULL
10-fold	NULL
molar	NULL
excess	NULL
of	NULL
peptide	NULL
over	NULL
class	NULL
II	NULL
molecules	NULL
.	NULL

Loading	NULL
was	NULL
conducted	NULL
at	NULL
37°C	NULL
for	NULL
72	NULL
h	NULL
in	NULL
a	NULL
100	NULL
mM	NULL
sodium	NULL
phosphate	NULL
buffer	NULL
,	NULL
pH	NULL
6	NULL
,	NULL
with	NULL
0.25	NULL
%	NULL
n-octylglucopyranoside	NULL
(	NULL
20	NULL
)	NULL
.	NULL

Class	NULL
II	NULL
tetramers	NULL
were	NULL
generated	NULL
by	NULL
incubating	NULL
an	NULL
8-fold	NULL
molar	NULL
excess	NULL
of	NULL
loaded	NULL
biotinylated	NULL
class	NULL
II	NULL
molecules	NULL
with	NULL
PE-streptavidin	NULL
(	NULL
BioSource	NULL
International	NULL
,	NULL
Camarillo	NULL
,	NULL
CA	NULL
)	NULL
at	NULL
room	NULL
temperature	NULL
for	NULL
4	NULL
h.	NULL
°	NULL
Abbreviations	NULL
used	NULL
in	NULL
this	NULL
paper	NULL
:	NULL
LZ	NULL
,	NULL
leucine	NULL
zipper	NULL
;	NULL
CFSE	NULL
,	NULL
5-	NULL
(	NULL
and	NULL
-6	NULL
)	NULL
-carboxyfluorescein	NULL
diacetate	NULL
succinimidy	NULL
]	NULL
ester	NULL
;	NULL
LCL	NULL
,	NULL
lymphoblastoid	NULL
cell	NULL
line	NULL
.	NULL

4245	NULL
Tetramer	NULL
analysis	NULL
of	NULL
T	NULL
cell	NULL
clones	NULL
and	NULL
PBMC	NULL
T	NULL
cell	NULL
clones	NULL
were	NULL
incubated	NULL
at	NULL
37°C	NULL
for	NULL
1-2	NULL
h	NULL
in	NULL
50	NULL
pl	NULL
media	NULL
with	NULL
20	NULL
pug/tal	NULL
tetramers/5	NULL
X	NULL
10°	NULL
cells	NULL
CD4-Cychrome	NULL
or	NULL
CD4-PerCP	NULL
(	NULL
Phar-Mingen	NULL
,	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
)	NULL
was	NULL
added	NULL
at	NULL
the	NULL
end	NULL
of	NULL
tetramer	NULL
staining	NULL
and	NULL
incubated	NULL
for	NULL
an	NULL
additional	NULL
15	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
washed	NULL
twice	NULL
with	NULL
PBS	NULL
+	NULL
1	NULL
%	NULL
FBS	NULL
before	NULL
analysis	NULL
by	NULL
a	NULL
Becton	NULL
Dickinson	NULL
FACSort	NULL
.	NULL

For	NULL
staining	NULL
of	NULL
PBMC	NULL
,	NULL
2	NULL
X	NULL
10°	NULL
nylon	NULL
wool-purified	NULL
T	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
VP16	NULL
protein	NULL
at	NULL
2	NULL
ug/ml	NULL
with	NULL
autologous	NULL
adherent	NULL
PBMC	NULL
as	NULL
APC	NULL
.	NULL

Adherent	NULL
PBMC	NULL
were	NULL
prepared	NULL
by	NULL
plating	NULL
out	NULL
PBMC	NULL
at	NULL
5	NULL
X	NULL
10°	NULL
cells/well	NULL
in	NULL
a	NULL
24-well	NULL
plate	NULL
.	NULL

Cells	NULL
were	NULL
allowed	NULL
to	NULL
adhere	NULL
overnight	NULL
,	NULL
and	NULL
nonadherent	NULL
cells	NULL
were	NULL
removed	NULL
with	NULL
a	NULL
plastic	NULL
pipette	NULL
.	NULL

The	NULL
nonadherent	NULL
cells	NULL
were	NULL
passed	NULL
through	NULL
a	NULL
nylon	NULL
wool	NULL
column	NULL
,	NULL
and	NULL
cells	NULL
eluted	NULL
from	NULL
the	NULL
column	NULL
were	NULL
used	NULL
as	NULL
nylon	NULL
wool-purified	NULL
T	NULL
cells	NULL
.	NULL

Starting	NULL
at	NULL
day	NULL
5	NULL
,	NULL
and	NULL
every	NULL
other	NULL
day	NULL
,	NULL
IL-2	NULL
was	NULL
added	NULL
to	NULL
a	NULL
final	NULL
concentration	NULL
of	NULL
10	NULL
U/ml	NULL
.	NULL

The	NULL
T	NULL
cells	NULL
were	NULL
stained	NULL
with	NULL
DQ0602/peptide	NULL
tetramers	NULL
10	NULL
days	NULL
later	NULL
.	NULL

Measurement	NULL
of	NULL
cell	NULL
divisions	NULL
and	NULL
precursor	NULL
frequency	NULL
PBMC	NULL
were	NULL
stained	NULL
with	NULL
0.8	NULL
M	NULL
5-	NULL
(	NULL
and	NULL
-6	NULL
)	NULL
-carboxyfluorescein	NULL
diacetate	NULL
succinimidy	NULL
]	NULL
ester	NULL
(	NULL
CFSE	NULL
;	NULL
Molecular	NULL
Probes	NULL
,	NULL
Eugene	NULL
,	NULL
OR	NULL
)	NULL
for	NULL
10	NULL
min	NULL
at	NULL
37°C	NULL
.	NULL

Staining	NULL
was	NULL
stopped	NULL
by	NULL
adding	NULL
100	NULL
%	NULL
FBS	NULL
and	NULL
subsequently	NULL
washing	NULL
the	NULL
cells	NULL
twice	NULL
in	NULL
RPMI	NULL
culture	NULL
media	NULL
.	NULL

Cells	NULL
were	NULL
then	NULL
plated	NULL
at	NULL
3	NULL
%	NULL
10°	NULL
cells/well	NULL
in	NULL
24-well	NULL
plates	NULL
and	NULL
stimulated	NULL
with	NULL
2	NULL
ug/ml	NULL
VP16	NULL
protein	NULL
overnight	NULL
.	NULL

Cells	NULL
were	NULL
stained	NULL
for	NULL
surface	NULL
markers	NULL
and	NULL
with	NULL
DQ0602/369-380	NULL
tetramers	NULL
or	NULL
control	NULL
tetramers	NULL
and	NULL
analyzed	NULL
by	NULL
FACS	NULL
after	NULL
10	NULL
days	NULL
in	NULL
culture	NULL
.	NULL

A	NULL
portion	NULL
of	NULL
the	NULL
CFSE-stained	NULL
cells	NULL
was	NULL
polyclonally	NULL
stimulated	NULL
with	NULL
2.5	NULL
pg/ml	NULL
PHA	NULL
and	NULL
10	NULL
U	NULL
IL-2	NULL
and	NULL
also	NULL
analyzed	NULL
by	NULL
FACS	NULL
on	NULL
day	NULL
10	NULL
.	NULL

Stimulation	NULL
of	NULL
T	NULL
cells	NULL
with	NULL
PHA	NULL
and	NULL
IL-2	NULL
results	NULL
in	NULL
cell	NULL
division	NULL
with	NULL
distinct	NULL
CFSE	NULL
fluorescence	NULL
peaks	NULL
,	NULL
allowing	NULL
determination	NULL
of	NULL
the	NULL
mean	NULL
CFSE	NULL
fluorescence	NULL
for	NULL
each	NULL
generation	NULL
.	NULL

These	NULL
values	NULL
were	NULL
used	NULL
to	NULL
calculate	NULL
the	NULL
average	NULL
number	NULL
of	NULL
cell	NULL
divisions	NULL
in	NULL
cells	NULL
stimulated	NULL
with	NULL
specific	NULL
Ag	NULL
.	NULL

Precursor	NULL
frequency	NULL
was	NULL
estimated	NULL
by	NULL
dividing	NULL
the	NULL
fraction	NULL
of	NULL
tetramer-positive	NULL
cells	NULL
by	NULL
2*	NULL
,	NULL
where	NULL
x	NULL
is	NULL
the	NULL
average	NULL
number	NULL
of	NULL
cell	NULL
divisions	NULL
as	NULL
calculated	NULL
by	NULL
CFSE	NULL
fluorescence	NULL
.	NULL

Peptide	NULL
binding	NULL
assays	NULL
Competition	NULL
peptide	NULL
binding	NULL
assays	NULL
with	NULL
purified	NULL
DQ0602	NULL
were	NULL
conducted	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
20	NULL
)	NULL
.	NULL

The	NULL
reaction	NULL
mixtures	NULL
consisted	NULL
of	NULL
25	NULL
nM	NULL
purified	NULL
DQ0602	NULL
,	NULL
0.1	NULL
M	NULL
biotinylated	NULL
IA-2	NULL
499-509	NULL
peptide	NULL
,	NULL
and	NULL
various	NULL
concentrations	NULL
of	NULL
nonbictinylated	NULL
VP16	NULL
369-380	NULL
or	NULL
VP16	NULL
33-52	NULL
peptides	NULL
.	NULL

The	NULL
peptide/class	NULL
II	NULL
complexes	NULL
were	NULL
captured	NULL
on	NULL
a	NULL
SPVL-3-coated	NULL
plate	NULL
and	NULL
measured	NULL
by	NULL
a	NULL
europium-labeled	NULL
streptavidin	NULL
assay	NULL
using	NULL
a	NULL
Delfia	NULL
1232	NULL
fluorometer	NULL
(	NULL
Wallac	NULL
,	NULL
Gaithersburg	NULL
,	NULL
MD	NULL
)	NULL
.	NULL

The	NULL
IC	NULL
,	NULL
,	NULL
was	NULL
determined	NULL
by	NULL
plotting	NULL
a	NULL
curve	NULL
and	NULL
extrapolating	NULL
the	NULL
concentration	NULL
at	NULL
which	NULL
50	NULL
%	NULL
inhibition	NULL
occurs	NULL
.	NULL

Analysis	NULL
of	NULL
TCR	NULL
genes	NULL
mRNA	NULL
was	NULL
prepared	NULL
from	NULL
T	NULL
cell	NULL
clones	NULL
using	NULL
the	NULL
Quick	NULL
Prep	NULL
Micro	NULL
RNA	NULL
Purification	NULL
Kit	NULL
(	NULL
Pharmacia	NULL
Biotech	NULL
,	NULL
Piscataway	NULL
,	NULL
NJ	NULL
)	NULL
.	NULL

cDNA	NULL
synthesis	NULL
was	NULL
conducted	NULL
using	NULL
the	NULL
Superscript	NULL
Preamplification	NULL
system	NULL
(	NULL
Life	NULL
Technolo-gies	NULL
)	NULL
.	NULL

TCR	NULL
VB	NULL
gene	NULL
usage	NULL
was	NULL
determined	NULL
by	NULL
PCR	NULL
amplification	NULL
of	NULL
cDNA	NULL
using	NULL
a	NULL
set	NULL
of	NULL
5°	NULL
VB	NULL
1-23	NULL
primers	NULL
and	NULL
3'-constant	NULL
region	NULL
primers	NULL
as	NULL
described	NULL
(	NULL
21	NULL
)	NULL
.	NULL

Results	NULL
and	NULL
Discussion	NULL
Identification	NULL
of	NULL
VP16	NULL
epitopes	NULL
recognized	NULL
by	NULL
HLA-DQ-restricted	NULL
T	NULL
cell	NULL
responses	NULL
The	NULL
tegument	NULL
protein	NULL
VP16	NULL
of	NULL
HSV-2	NULL
virus	NULL
is	NULL
one	NULL
of	NULL
the	NULL
major	NULL
proteins	NULL
recognized	NULL
as	NULL
a	NULL
viral	NULL
Ag	NULL
in	NULL
HSV-2-infected	NULL
subjects	NULL
(	NULL
22	NULL
)	NULL
.	NULL

Forty-eight	NULL
T	NULL
cell	NULL
clones	NULL
were	NULL
isolated	NULL
from	NULL
peripheral	NULL
blood	NULL
of	NULL
an	NULL
HSV-2-infected	NULL
individual	NULL
that	NULL
were	NULL
specific	NULL
for	NULL
the	NULL
HSV-2	NULL
VP16	NULL
protein	NULL
.	NULL

Proliferation	NULL
assays	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
either	NULL
an	NULL
anti-DR	NULL
or	NULL
anti-DQ	NULL
Ab	NULL
indicated	NULL
that	NULL
seven	NULL
of	NULL
these	NULL
clones	NULL
were	NULL
restricted	NULL
by	NULL
DQ0602	NULL
,	NULL
the	NULL
only	NULL
DQ	NULL
molecule	NULL
in	NULL
common	NULL
to	NULL
both	NULL
the	NULL
responders	NULL
and	NULL
the	NULL
APC	NULL
(	NULL
see	NULL
Materials	NULL
and	NULL
Methods	NULL
)	NULL
.	NULL

Fig	NULL
.	NULL

1	NULL
illustrates	NULL
the	NULL
proliferation	NULL
of	NULL
two	NULL
of	NULL
these	NULL
T	NULL
cell	NULL
clones	NULL
,	NULL
c5	NULL
and	NULL
c44	NULL
,	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
VP16	NULL
protein	NULL
and	NULL
BLS-DQ0602	NULL
B-lymphoblastoid	NULL
cell	NULL
line	NULL
(	NULL
LCL	NULL
)	NULL
as	NULL
APC	NULL
.	NULL

The	NULL
BLS-DQ0602	NULL
LCL	NULL
is	NULL
an	NULL
EBV-trans-formed	NULL
human	NULL
B	NULL
cell	NULL
line	NULL
that	NULL
was	NULL
transfected	NULL
with	NULL
DQ	NULL
genes	NULL
and	NULL
had	NULL
DQO0602	NULL
as	NULL
the	NULL
only	NULL
expressed	NULL
class	NULL
II	NULL
molecule	NULL
(	NULL
16	NULL
)	NULL
,	NULL
confirming	NULL
that	NULL
DQO0602	NULL
was	NULL
the	NULL
restriction	NULL
element	NULL
for	NULL
these	NULL
T	NULL
cell	NULL
clones	NULL
.	NULL

To	NULL
determine	NULL
the	NULL
dominant	NULL
DQ0602-restricted	NULL
epitope	NULL
for	NULL
the	NULL
VP16	NULL
protein	NULL
,	NULL
all	NULL
7	NULL
T	NULL
cell	NULL
clones	NULL
were	NULL
screened	NULL
with	NULL
a	NULL
panel	NULL
of	NULL
6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
4246	NULL
clone	NULL
c5	NULL
50000	NULL
as	NULL
o	NULL
=i	NULL
o	NULL
=	NULL
]	NULL
30000	NULL
[	NULL
°H	NULL
]	NULL
Thymidine	NULL
incorporation	NULL
(	NULL
cpm	NULL
)	NULL
pmed	NULL
:	NULL
0	NULL
no	NULL
VP16	NULL
VP16	NULL
HLA-DQ	NULL
TETRAMERS	NULL
DETECT	NULL
HSV-2-SPECIFIC	NULL
T	NULL
CELLS	NULL
clone	NULL
c44	NULL
75000	NULL
ing	NULL
50000	NULL
[	NULL
°H	NULL
]	NULL
Thymid	NULL
incorporation	NULL
(	NULL
cpm	NULL
)	NULL
25000	NULL
no	NULL
VP16	NULL
VP16	NULL
FIGURE	NULL
1	NULL
.	NULL

Identification	NULL
of	NULL
DQ0602-restricted	NULL
T	NULL
cells	NULL
specific	NULL
for	NULL
HSV-2	NULL
VP16	NULL
protein	NULL
.	NULL

T	NULL
cell	NULL
clones	NULL
that	NULL
were	NULL
isolated	NULL
from	NULL
5491	NULL
were	NULL
stimulated	NULL
with	NULL
1	NULL
pg/ml	NULL
VP16	NULL
with	NULL
BLS.0602	NULL
LCL	NULL
as	NULL
APC	NULL
.	NULL

After	NULL
48	NULL
h	NULL
,	NULL
1	NULL
mCi	NULL
[	NULL
H	NULL
]	NULL
thymidine	NULL
was	NULL
added	NULL
,	NULL
and	NULL
the	NULL
cells	NULL
were	NULL
harvested	NULL
and	NULL
counted	NULL
16	NULL
h	NULL
later	NULL
.	NULL

60	NULL
overlapping	NULL
peptides	NULL
that	NULL
covered	NULL
the	NULL
entire	NULL
VP16	NULL
protein	NULL
.	NULL

Six	NULL
of	NULL
the	NULL
seven	NULL
DQ-restricted	NULL
clones	NULL
,	NULL
c5	NULL
,	NULL
c8	NULL
,	NULL
c31	NULL
,	NULL
c48	NULL
,	NULL
c68	NULL
,	NULL
and	NULL
©73	NULL
,	NULL
were	NULL
specific	NULL
for	NULL
both	NULL
peptides	NULL
361-380	NULL
(	NULL
AYSRGRTRNNYGSTIEGLLD	NULL
)	NULL
and	NULL
369-388	NULL
(	NULL
NNYGSTIEGLLDLPDDDDAP	NULL
)	NULL
.	NULL

Truncation	NULL
analysis	NULL
of	NULL
the	NULL
peptides	NULL
indicated	NULL
that	NULL
all	NULL
6	NULL
clones	NULL
recognize	NULL
peptide	NULL
369-380	NULL
(	NULL
NNYGSTIEGLLD	NULL
)	NULL
.	NULL

The	NULL
other	NULL
clone	NULL
,	NULL
c44	NULL
,	NULL
was	NULL
shown	NULL
to	NULL
recognize	NULL
the	NULL
VP16	NULL
peptide	NULL
33-52	NULL
(	NULL
PPLYATGRLSQAQLMPSPPM	NULL
)	NULL
.	NULL

The	NULL
reactivity	NULL
profiles	NULL
of	NULL
clone	NULL
c5	NULL
and	NULL
c44	NULL
to	NULL
the	NULL
panel	NULL
of	NULL
overlapping	NULL
VP16	NULL
peptides	NULL
are	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

TCR	NULL
VB	NULL
transcripts	NULL
in	NULL
clones	NULL
that	NULL
recognized	NULL
369-380	NULL
were	NULL
identified	NULL
by	NULL
RT-PCR	NULL
analysis	NULL
using	NULL
a	NULL
set	NULL
of	NULL
VB	NULL
primers	NULL
.	NULL

Two	NULL
different	NULL
VB-chains	NULL
were	NULL
identified	NULL
:	NULL
clones	NULL
c5	NULL
,	NULL
c8	NULL
,	NULL
c31	NULL
,	NULL
and	NULL
c68	NULL
used	NULL
V	NULL
6.5	NULL
;	NULL
and	NULL
clones	NULL
c48	NULL
and	NULL
c73	NULL
used	NULL
VB	NULL
13.2	NULL
.	NULL

DQ0602/peptide	NULL
tetramers	NULL
were	NULL
generated	NULL
with	NULL
either	NULL
the	NULL
33-52	NULL
peptide	NULL
or	NULL
the	NULL
369-380	NULL
peptide	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
and	NULL
incubated	NULL
with	NULL
T	NULL
cell	NULL
clones	NULL
c5	NULL
and	NULL
c44	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
tetramer	NULL
staining	NULL
was	NULL
specific	NULL
for	NULL
T	NULL
cells	NULL
with	NULL
corresponding	NULL
functional	NULL
specificity	NULL
:	NULL
Clone	NULL
c5	NULL
T	NULL
cells	NULL
,	NULL
which	NULL
proliferated	NULL
to	NULL
peptide	NULL
369-380	NULL
,	NULL
could	NULL
be	NULL
stained	NULL
only	NULL
by	NULL
the	NULL
DQO0602	NULL
tetramers	NULL
loaded	NULL
with	NULL
peptide	NULL
369-380	NULL
but	NULL
not	NULL
by	NULL
the	NULL
tetramers	NULL
loaded	NULL
with	NULL
peptide	NULL
33-52	NULL
,	NULL
whereas	NULL
clone	NULL
c44	NULL
T	NULL
cells	NULL
,	NULL
which	NULL
proliferated	NULL
to	NULL
peptide	NULL
33-52	NULL
,	NULL
could	NULL
be	NULL
stained	NULL
only	NULL
by	NULL
tetramers	NULL
loaded	NULL
with	NULL
peptide	NULL
33-52	NULL
.	NULL

Epitope	NULL
specificity	NULL
of	NULL
DQO6O2-restricted	NULL
T	NULL
cells	NULL
from	NULL
peripheral	NULL
blood	NULL
of	NULL
individuals	NULL
infected	NULL
with	NULL
HSV-2	NULL
Peripheral	NULL
blood	NULL
lymphocytes	NULL
from	NULL
individual	NULL
5491	NULL
were	NULL
incubated	NULL
with	NULL
VP16	NULL
protein	NULL
in	NULL
vitro	NULL
and	NULL
stained	NULL
with	NULL
the	NULL
DQ0602/	NULL
clone	NULL
c5	NULL
€	NULL
§	NULL
§	NULL
€	NULL
[	NULL
JH	NULL
]	NULL
Thymidine	NULL
Incorporation	NULL
(	NULL
cpm	NULL
)	NULL
§	NULL
100007	NULL
e	NULL
resend	NULL
$	NULL
0.0	NULL
9	NULL
2	NULL
o	NULL
5	NULL
a	NULL
5	NULL
6	NULL
a	NULL
o	NULL
a	NULL
o	NULL
i	NULL
a	NULL
6	NULL
i	NULL
6	NULL
B	NULL
68	NULL
6	NULL
Ai	NULL
h	NULL
h	NULL
fra	NULL
6	NULL
B	NULL
.	NULL

hc	NULL
0	NULL
a.	NULL
o	NULL
0	NULL
o	NULL
o	NULL
o	NULL
t	NULL
a	NULL
a	NULL
a	NULL
o	NULL
a	NULL
o	NULL
n	NULL
a	NULL
aa	NULL
a	NULL
ea	NULL
i	NULL
€s	NULL
Antigen	NULL
(	NULL
1	NULL
uM	NULL
)	NULL
peptide	NULL
tetramers	NULL
10	NULL
days	NULL
later	NULL
.	NULL

T	NULL
cells	NULL
identified	NULL
by	NULL
both	NULL
the	NULL
DQ0602/369-380	NULL
and	NULL
DQ0602/33-52	NULL
tetramers	NULL
were	NULL
detected	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
A	NULL
and	NULL
B	NULL
)	NULL
.	NULL

T	NULL
cells	NULL
that	NULL
stained	NULL
with	NULL
the	NULL
DQ0602/369-380	NULL
tetramers	NULL
were	NULL
observed	NULL
at	NULL
a	NULL
higher	NULL
frequency	NULL
(	NULL
3.3	NULL
%	NULL
)	NULL
than	NULL
the	NULL
T	NULL
cells	NULL
stained	NULL
with	NULL
the	NULL
DQ0602/33-52	NULL
tetramers	NULL
(	NULL
0.6	NULL
%	NULL
)	NULL
.	NULL

This	NULL
observation	NULL
was	NULL
consistent	NULL
with	NULL
the	NULL
observation	NULL
in	NULL
T	NULL
cell	NULL
cloning	NULL
that	NULL
clones	NULL
specific	NULL
for	NULL
epitope	NULL
369-380	NULL
were	NULL
observed	NULL
at	NULL
a	NULL
much	NULL
higher	NULL
frequency	NULL
than	NULL
the	NULL
33-52	NULL
epitope	NULL
.	NULL

Similar	NULL
staining	NULL
patterns	NULL
with	NULL
the	NULL
DQ0602/369-380	NULL
tetramers	NULL
were	NULL
also	NULL
observed	NULL
with	NULL
peripheral	NULL
blood	NULL
T	NULL
cells	NULL
from	NULL
two	NULL
additional	NULL
HSV-2	NULL
infected	NULL
individuals	NULL
who	NULL
carried	NULL
the	NULL
DQ0602	NULL
haplotype	NULL
:	NULL
5624	NULL
(	NULL
DRB1*1501/1101	NULL
,	NULL
DQB1*0602/0301	NULL
)	NULL
and	NULL
5633	NULL
(	NULL
DRB1*1501	NULL
,	NULL
/0801	NULL
,	NULL
DQB	NULL
1*0602/0402	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
C	NULL
and	NULL
D	NULL
)	NULL
.	NULL

T	NULL
cells	NULL
corresponding	NULL
to	NULL
the	NULL
33-52	NULL
epitope	NULL
were	NULL
not	NULL
detected	NULL
in	NULL
these	NULL
two	NULL
individuals	NULL
.	NULL

Analysis	NULL
with	NULL
the	NULL
DQ0602/369-380	NULL
and	NULL
33-52	NULL
tetramers	NULL
was	NULL
Ag	NULL
and	NULL
MHC	NULL
specific	NULL
.	NULL

No	NULL
staining	NULL
with	NULL
either	NULL
tetramer	NULL
was	NULL
detected	NULL
in	NULL
HSV-2-infected	NULL
individual	NULL
5707	NULL
(	NULL
DRB1*O0101/1101	NULL
,	NULL
DQB1*0501/	NULL
0301	NULL
)	NULL
who	NULL
did	NULL
not	NULL
carry	NULL
the	NULL
DQ0602	NULL
allele	NULL
or	NULL
in	NULL
HLA-DQ0602	NULL
HSV-2	NULL
serological	NULL
negative	NULL
individual	NULL
5001	NULL
(	NULL
DRB1*1501/0301	NULL
,	NULL
DQB1*0602/0201	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
E	NULL
and	NULL
F	NULL
)	NULL
.	NULL

No	NULL
staining	NULL
was	NULL
observed	NULL
with	NULL
tetramers	NULL
that	NULL
were	NULL
loaded	NULL
with	NULL
a	NULL
DQ0602	NULL
high	NULL
binding	NULL
affinity	NULL
peptide	NULL
,	NULL
insulin	NULL
B	NULL
5-15	NULL
(	NULL
20	NULL
)	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Precursor	NULL
frequency	NULL
of	NULL
DQO6O2-restricted	NULL
T	NULL
cells	NULL
in	NULL
peripheral	NULL
blood	NULL
To	NULL
estimate	NULL
the	NULL
initial	NULL
frequency	NULL
of	NULL
DQ0602/369-380	NULL
T	NULL
cells	NULL
present	NULL
in	NULL
the	NULL
peripheral	NULL
blood	NULL
of	NULL
the	NULL
HSV-2-infected	NULL
individuals	NULL
,	NULL
clone	NULL
c44	NULL
soo00-50000	NULL
«	NULL
00004	NULL
$	NULL
20000	NULL
[	NULL
3H1Thymidine	NULL
Incorporation	NULL
(	NULL
cpm	NULL
)	NULL
100004	NULL
NNNNN	NULL
nnnnnnnnnnnnnnnnnnnnnnnnnnnnn	NULL
Antigen	NULL
(	NULL
1	NULL
pM	NULL
)	NULL
FIGURE	NULL
2	NULL
.	NULL

Identification	NULL
of	NULL
DQ0602-restricted	NULL
epitopes	NULL
in	NULL
HSV-2	NULL
VP16	NULL
protein	NULL
.	NULL

T	NULL
cell	NULL
clone	NULL
c5	NULL
and	NULL
c44	NULL
were	NULL
stimulated	NULL
with	NULL
1	NULL
pg/ml	NULL
VP16	NULL
protein	NULL
or	NULL
a	NULL
panel	NULL
of	NULL
overlapping	NULL
VP16	NULL
peptides	NULL
,	NULL
at	NULL
1	NULL
M	NULL
with	NULL
HLA-DQ-matched	NULL
PBMC	NULL
as	NULL
APC	NULL
.	NULL

After	NULL
48	NULL
h	NULL
,	NULL
1	NULL
mCi	NULL
[	NULL
H	NULL
]	NULL
thymidine	NULL
was	NULL
added	NULL
,	NULL
and	NULL
the	NULL
cells	NULL
were	NULL
harvested	NULL
and	NULL
counted	NULL
16	NULL
h	NULL
later	NULL
.	NULL

6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
3	NULL
c5	NULL
3	NULL
c5	NULL
A	NULL
-	NULL
§8	NULL
B	NULL
$	NULL
8	NULL
]	NULL
@	NULL
a	NULL
©	NULL
n	NULL
$	NULL
2	NULL
]	NULL
52	NULL
a	NULL
go	NULL
)	NULL
¥	NULL
3°	NULL
3s	NULL
|	NULL
i	NULL
[	NULL
=¥3	NULL
ag	NULL
2	NULL
l	NULL
10°	NULL
10	NULL
``	NULL
10°	NULL
10°	NULL
10	NULL
10°	NULL
10°	NULL
40°	NULL
10°	NULL
10+	NULL
CD4	NULL
CD4	NULL
&	NULL
c44	NULL
5	NULL
c-	NULL
$	NULL
2	NULL
D	NULL
g	NULL
?	NULL

$	NULL
8	NULL
]	NULL
$	NULL
8	NULL
gF-1	NULL
8	NULL
~	NULL
a-	NULL
©	NULL
fret	NULL
a	NULL
66	NULL
a	NULL
m4	NULL
a	NULL
-J	NULL
3	NULL
,	NULL
#	NULL
8.	NULL
ab	NULL
3	NULL
Ad	NULL
10	NULL
``	NULL
10°	NULL
10°	NULL
10°	NULL
10°	NULL
10	NULL
``	NULL
10°	NULL
10°	NULL
10*	NULL
CD4	NULL
CD4	NULL
FIGURE	NULL
3	NULL
.	NULL

-	NULL
Staining	NULL
of	NULL
DQO602-restricted	NULL
T	NULL
cell	NULL
clones	NULL
with	NULL
DQ0602/	NULL
peptide	NULL
tetramers	NULL
.	NULL

A	NULL
,	NULL
Staining	NULL
of	NULL
c5	NULL
with	NULL
DQ0602/369-380	NULL
;	NULL
B	NULL
,	NULL
staining	NULL
of	NULL
c5	NULL
with	NULL
DQ0602/33-52	NULL
.	NULL

C	NULL
,	NULL
staining	NULL
of	NULL
c44	NULL
with	NULL
DQ0602/369-380	NULL
;	NULL
D	NULL
,	NULL
staining	NULL
of	NULL
c44	NULL
with	NULL
DQ0602/33-52	NULL
.	NULL

01	NULL
%	NULL
0.0	NULL
%	NULL
0.6	NULL
%	NULL
a	NULL
a	NULL
5491	NULL
gt	NULL
ye	NULL
A	NULL
05:1	NULL
B	NULL
“	NULL
m1	NULL
©	NULL
o	NULL
2o	NULL
§-	NULL
3°	NULL
Cl	NULL
[	NULL
=	NULL
-o	NULL
#	NULL
2	NULL
3o	NULL
wigs	NULL
.	NULL

5	NULL
10°	NULL
10°	NULL
10°	NULL
10°	NULL
10°	NULL
10°	NULL
10	NULL
``	NULL
10°	NULL
10°	NULL
10°	NULL
111	NULL
%	NULL
CD4	NULL
85.5	NULL
%	NULL
10.9	NULL
%	NULL
CD4	NULL
88.5	NULL
%	NULL
0.0	NULL
%	NULL
16	NULL
%	NULL
01	NULL
%	NULL
1.0	NULL
%	NULL
5	NULL
5624	NULL
5	NULL
5633	NULL
a	NULL
``	NULL
c	NULL
§P	NULL
p	NULL
§2	NULL
o	NULL
d.	NULL
8	NULL
:	NULL
€2	NULL
go	NULL
$	NULL
Ga	NULL
]	NULL
3	NULL
ag	NULL
k	NULL
as	NULL
ﬁg	NULL
10°	NULL
10°	NULL
10°	NULL
10°	NULL
10¢	NULL
10°	NULL
10	NULL
``	NULL
10°	NULL
10°	NULL
10+	NULL
77	NULL
%	NULL
CD4	NULL
88.7	NULL
%	NULL
23.8	NULL
%	NULL
CO4	NULL
75.2	NULL
%	NULL
.	NULL

0.0	NULL
%	NULL
01	NULL
%	NULL
8	NULL
5707	NULL
=	NULL
2	NULL
5001	NULL
§	NULL
%	NULL
(	NULL
8:6	NULL
E	NULL
$	NULL
5	NULL
F	NULL
gy	NULL
]	NULL
$	NULL
7	NULL
<	NULL
$	NULL
2	NULL
)	NULL
S	NULL
%	NULL
Es	NULL
.	NULL

4s	NULL
}	NULL
.	NULL

10	NULL
``	NULL
10	NULL
``	NULL
104	NULL
10°	NULL
19¢	NULL
10°	NULL
10°	NULL
10°	NULL
10°	NULL
40*	NULL
17.9	NULL
%	NULL
CD4	NULL
82.0	NULL
%	NULL
34.6	NULL
%	NULL
co4	NULL
65.4	NULL
%	NULL
FIGURE	NULL
4	NULL
.	NULL

Staining	NULL
of	NULL
DQ0602-restricted	NULL
T	NULL
cells	NULL
from	NULL
PBMC	NULL
using	NULL
specific	NULL
tetramers	NULL
.	NULL

PBMC	NULL
from	NULL
DQ0602	NULL
HSV	NULL
-2-infected	NULL
patient	NULL
5491	NULL
were	NULL
stimulated	NULL
with	NULL
VP16	NULL
protein	NULL
and	NULL
then	NULL
stained	NULL
with	NULL
DQ0602/369-380	NULL
(	NULL
4	NULL
)	NULL
or	NULL
DQ0602/33-52	NULL
(	NULL
B	NULL
)	NULL
tetramer	NULL
10	NULL
days	NULL
later	NULL
.	NULL

PBMC	NULL
from	NULL
DQ0602	NULL
HSV-2-infected	NULL
subjects	NULL
,	NULL
5624	NULL
(	NULL
C	NULL
)	NULL
and	NULL
5633	NULL
(	NULL
D	NULL
)	NULL
,	NULL
were	NULL
stained	NULL
with	NULL
DQ0602/	NULL
369-380	NULL
tetramers	NULL
.	NULL

PBMC	NULL
from	NULL
a	NULL
non	NULL
DQ0602	NULL
HSV-2-infected	NULL
subject	NULL
5707	NULL
(	NULL
E	NULL
)	NULL
and	NULL
a	NULL
normal	NULL
DQ0602	NULL
individual	NULL
5001	NULL
(	NULL
F	NULL
)	NULL
were	NULL
stained	NULL
with	NULL
DQ0602/369-380	NULL
tetramers	NULL
.	NULL

Percentages	NULL
shown	NULL
in	NULL
the	NULL
margins	NULL
represent	NULL
the	NULL
percent	NULL
of	NULL
total	NULL
cells	NULL
present	NULL
in	NULL
each	NULL
quadrant	NULL
.	NULL

4247	NULL
A	NULL
o	NULL
uw	NULL
a	NULL
.	NULL

5	NULL
[	NULL
=	NULL
21	NULL
%	NULL
é	NULL
0.2	NULL
%	NULL
E	NULL
4	NULL
o	NULL
a	NULL
[	NULL
eod	NULL
©	NULL
E	NULL
$	NULL
O	NULL
&	NULL
©	NULL
se	NULL
A	NULL
(	NULL
res	NULL
19.8	NULL
%	NULL
°	NULL
77.9	NULL
%	NULL
&	NULL
ej	NULL
0	NULL
6	NULL
CFSE	NULL
FIGURE	NULL
5	NULL
.	NULL

Proliferation	NULL
of	NULL
DQ0602/369-380	NULL
tetramer-positive	NULL
T	NULL
cells	NULL
after	NULL
VP16	NULL
Ag	NULL
stimulation	NULL
.	NULL

PBMC	NULL
from	NULL
DQ0602	NULL
HSV-2-infected	NULL
patient	NULL
5491	NULL
were	NULL
stained	NULL
with	NULL
CFSE	NULL
and	NULL
stimulated	NULL
with	NULL
VP16	NULL
protein	NULL
.	NULL

After	NULL
a	NULL
10-day	NULL
culture	NULL
,	NULL
cells	NULL
were	NULL
stained	NULL
for	NULL
surface	NULL
markers	NULL
and	NULL
with	NULL
DQ0602/	NULL
369-380	NULL
tetramer	NULL
.	NULL

Ordinate	NULL
,	NULL
PE	NULL
fluorescence	NULL
of	NULL
the	NULL
DQ0602/369-380	NULL
tet-ramer	NULL
;	NULL
abscissa	NULL
,	NULL
CFSE	NULL
fluorescence	NULL
over	NULL
a	NULL
4-decade	NULL
logarithmic	NULL
scale	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
the	NULL
abscissa	NULL
shows	NULL
the	NULL
corresponding	NULL
number	NULL
of	NULL
cell	NULL
divisions	NULL
,	NULL
with	NULL
P	NULL
representing	NULL
the	NULL
undivided	NULL
parent	NULL
population	NULL
.	NULL

This	NULL
scale	NULL
was	NULL
calculated	NULL
from	NULL
the	NULL
distinct	NULL
fluorescence	NULL
peaks	NULL
produced	NULL
by	NULL
polyclonal	NULL
stimulation	NULL
with	NULL
PHA	NULL
and	NULL
IL-2	NULL
as	NULL
described	NULL
in	NULL
the	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

Percentages	NULL
shown	NULL
in	NULL
the	NULL
margins	NULL
represent	NULL
the	NULL
percent	NULL
of	NULL
total	NULL
cells	NULL
present	NULL
in	NULL
each	NULL
quadrant	NULL
.	NULL

we	NULL
combined	NULL
the	NULL
use	NULL
of	NULL
specific	NULL
tetramer	NULL
staining	NULL
with	NULL
another	NULL
fluorescent-based	NULL
technique	NULL
that	NULL
quantitates	NULL
cell	NULL
divisions	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
after	NULL
10	NULL
days	NULL
of	NULL
culture	NULL
,	NULL
T	NULL
cells	NULL
from	NULL
individual	NULL
5491	NULL
staining	NULL
positive	NULL
with	NULL
DQ0602/369-380	NULL
tetramer	NULL
are	NULL
found	NULL
predominantly	NULL
in	NULL
the	NULL
CFSE-dull	NULL
quadrant	NULL
of	NULL
the	NULL
fluorescence	NULL
pro-file	NULL
.	NULL

The	NULL
mean	NULL
CFSE	NULL
fluorescence	NULL
of	NULL
these	NULL
cells	NULL
corresponds	NULL
to	NULL
~10	NULL
cell	NULL
divisions	NULL
.	NULL

The	NULL
observed	NULL
frequency	NULL
of	NULL
2.1	NULL
%	NULL
for	NULL
tetramer-positive	NULL
cells	NULL
after	NULL
10	NULL
cell	NULL
divisions	NULL
indicates	NULL
an	NULL
initial	NULL
precursor	NULL
frequency	NULL
of	NULL
0.002	NULL
%	NULL
.	NULL

Peptide	NULL
binding	NULL
affinity	NULL
and	NULL
T	NULL
cell	NULL
epitope	NULL
Peptide	NULL
binding	NULL
studies	NULL
for	NULL
the	NULL
DQ0602	NULL
molecule	NULL
were	NULL
performed	NULL
to	NULL
compare	NULL
the	NULL
class	NULL
II-peptide	NULL
avidity	NULL
of	NULL
the	NULL
two	NULL
VP16	NULL
epitopes	NULL
,	NULL
369-380	NULL
and	NULL
33-52	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

6	NULL
,	NULL
peptide	NULL
369-380	NULL
has	NULL
an	NULL
ICs	NULL
,	NULL
of	NULL
2	NULL
uM	NULL
,	NULL
whereas	NULL
peptide	NULL
33-52	NULL
has	NULL
an	NULL
IC	NULL
,	NULL
,	NULL
of	NULL
0.4	NULL
uM	NULL
.	NULL

Because	NULL
this	NULL
binding	NULL
avidity	NULL
is	NULL
inversely	NULL
related	NULL
to	NULL
the	NULL
frequency	NULL
of	NULL
epitope-specific	NULL
T	NULL
cells	NULL
observed	NULL
,	NULL
this	NULL
indicates	NULL
that	NULL
the	NULL
relative	NULL
higher	NULL
frequency	NULL
of	NULL
369-380	NULL
T	NULL
cells	NULL
was	NULL
not	NULL
directly	NULL
due	NULL
to	NULL
a	NULL
high	NULL
affinity	NULL
of	NULL
369-380	NULL
for	NULL
DQO0602	NULL
but	NULL
likely	NULL
results	NULL
from	NULL
a	NULL
more	NULL
0	NULL
in	NULL
4000	NULL
--	NULL
VP16	NULL
33-52	NULL
=	NULL
--	NULL
+	NULL
--	NULL
VP16	NULL
369-380	NULL
35	NULL
30000	NULL
®	NULL
o	NULL
C	NULL
8	NULL
20000	NULL
t	NULL
©	NULL
0	NULL
2	NULL
10000	NULL
IL	NULL
0~	NULL
p	NULL
t	NULL
1	NULL
t	NULL
:	NULL
0.001	NULL
_	NULL
0.01	NULL
0.1	NULL
1	NULL
10	NULL
100	NULL
peptide	NULL
concentration	NULL
in	NULL
uM	NULL
FIGURE	NULL
6	NULL
.	NULL

-	NULL
Binding	NULL
of	NULL
VP16	NULL
peptides	NULL
to	NULL
DQ0602	NULL
.	NULL

Purified	NULL
DQ0602	NULL
(	NULL
25	NULL
nM	NULL
)	NULL
was	NULL
incubated	NULL
with	NULL
0.1	NULL
uM	NULL
biotinylated	NULL
IA-2	NULL
499-509	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
various	NULL
concentrations	NULL
of	NULL
VP16	NULL
369-380	NULL
or	NULL
VP16	NULL
33-52	NULL
peptides	NULL
.	NULL

Bound	NULL
biotinylated	NULL
peptide	NULL
was	NULL
detected	NULL
by	NULL
fluorescence	NULL
using	NULL
a	NULL
europium-labeled	NULL
streptavidin	NULL
system	NULL
with	NULL
a	NULL
Delfia	NULL
1232	NULL
fluorometer	NULL
.	NULL

6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
4248	NULL
Table	NULL
I	NULL
.	NULL

Proliferation	NULL
of	NULL
tetramer	NULL
sorted	NULL
cells	NULL
to	NULL
VP16	NULL
369-380	NULL
peptide	NULL
and	NULL
staining	NULL
with	NULL
DQ0602/369-380	NULL
tetramer	NULL
Cell	NULL
FACS	NULL
Lines	NULL
A	NULL
cpm*	NULL
Fluorescence	NULL
``	NULL
1	NULL
26,101	NULL
+++	NULL
2	NULL
615	NULL
3	NULL
21,978	NULL
++	NULL
4	NULL
115	NULL
5	NULL
14,313	NULL
++	NULL
6	NULL
-24	NULL
7	NULL
18,538	NULL
+	NULL
8	NULL
47,307	NULL
+	NULL
9	NULL
52,076	NULL
+++	NULL
10	NULL
12,839	NULL
+++	NULL
11	NULL
12,013	NULL
++	NULL
12	NULL
-20	NULL
13	NULL
55,345	NULL
++	NULL
14	NULL
34,898	NULL
+++	NULL
15	NULL
86,308	NULL
++	NULL
16	NULL
57,133	NULL
++	NULL
17	NULL
-267	NULL
18	NULL
68,799	NULL
+++	NULL
19	NULL
7,070	NULL
+	NULL
20	NULL
26,946	NULL
+++	NULL
21	NULL
79,804	NULL
+++	NULL
22	NULL
411	NULL
23	NULL
12,464	NULL
+	NULL
24	NULL
280	NULL
25	NULL
-77	NULL
26	NULL
12,618	NULL
+++	NULL
27	NULL
27,685	NULL
+	NULL
28	NULL
51,786	NULL
+++	NULL
29	NULL
15,738	NULL
+	NULL
30	NULL
22,004	NULL
+++	NULL
31	NULL
20,104	NULL
+++	NULL
32	NULL
9,045	NULL
+	NULL
33	NULL
18,071	NULL
++	NULL
34	NULL
1,210	NULL
35	NULL
20,571	NULL
+++	NULL
36	NULL
114,099	NULL
+++	NULL
37	NULL
163,628	NULL
+++	NULL
38	NULL
118,384	NULL
+++	NULL
39	NULL
103,449	NULL
+++	NULL
40	NULL
25,832	NULL
+++	NULL
41	NULL
-44	NULL
42	NULL
71,533	NULL
++	NULL
43	NULL
-21	NULL
44	NULL
33,413	NULL
++	NULL
45	NULL
58,385	NULL
++	NULL
46	NULL
22,095	NULL
+++	NULL
47	NULL
80,454	NULL
++	NULL
*	NULL
Acpm	NULL
represents	NULL
(	NULL
cpm	NULL
with	NULL
1	NULL
uM	NULL
369-380	NULL
peptide	NULL
)	NULL
-	NULL
(	NULL
cpm	NULL
without	NULL
peptide	NULL
)	NULL
in	NULL
the	NULL
proliferation	NULL
assays	NULL
.	NULL

*	NULL
For	NULL
FACS	NULL
fluorescence	NULL
,	NULL
+	NULL
represent	NULL
1-	NULL
to	NULL
10-fold	NULL
above	NULL
background	NULL
,	NULL
++	NULL
represent	NULL
10-	NULL
to	NULL
100-fold	NULL
above	NULL
background	NULL
,	NULL
and	NULL
+++	NULL
represents	NULL
>	NULL
100-fold	NULL
above	NULL
background	NULL
.	NULL

complex	NULL
set	NULL
of	NULL
parameters	NULL
associated	NULL
with	NULL
selection	NULL
of	NULL
immunodominant	NULL
epitopes	NULL
,	NULL
possibly	NULL
including	NULL
differential	NULL
T	NULL
cell	NULL
selection	NULL
or	NULL
variable	NULL
processing	NULL
of	NULL
the	NULL
VP16	NULL
protein	NULL
,	NULL
enabling	NULL
the	NULL
369-380	NULL
epitope	NULL
to	NULL
be	NULL
preferentially	NULL
processed	NULL
compared	NULL
with	NULL
the	NULL
33-52	NULL
epitope	NULL
.	NULL

This	NULL
is	NULL
compatible	NULL
with	NULL
x-ray	NULL
crystallography	NULL
structural	NULL
studies	NULL
in	NULL
which	NULL
the	NULL
carboxyl-terminal	NULL
region	NULL
of	NULL
the	NULL
VP16	NULL
protein	NULL
has	NULL
a	NULL
disordered	NULL
structure	NULL
(	NULL
23	NULL
)	NULL
,	NULL
potentially	NULL
allowing	NULL
this	NULL
region	NULL
easy	NULL
access	NULL
to	NULL
protease	NULL
and	NULL
capture	NULL
by	NULL
class	NULL
II	NULL
molecules	NULL
.	NULL

This	NULL
is	NULL
also	NULL
consistent	NULL
with	NULL
a	NULL
general	NULL
property	NULL
of	NULL
this	NULL
part	NULL
of	NULL
the	NULL
VP16	NULL
molecule	NULL
,	NULL
rather	NULL
than	NULL
specific	NULL
for	NULL
DQ0602	NULL
determinant	NULL
selection	NULL
,	NULL
because	NULL
previous	NULL
studies	NULL
have	NULL
also	NULL
demonstrated	NULL
that	NULL
the	NULL
carboxyl	NULL
terminal	NULL
of	NULL
the	NULL
VP16	NULL
contained	NULL
numerous	NULL
T	NULL
cell	NULL
epitopes	NULL
(	NULL
22	NULL
)	NULL
.	NULL

HLA-DQ	NULL
TETRAMERS	NULL
DETECT	NULL
HSV-2-SPECIFIC	NULL
T	NULL
CELLS	NULL
Fluorescence-activated	NULL
cell	NULL
sorting	NULL
with	NULL
DQ	NULL
tetramers	NULL
The	NULL
specificity	NULL
of	NULL
T	NULL
cells	NULL
detected	NULL
with	NULL
the	NULL
DQ0602/369-380	NULL
tetramer	NULL
was	NULL
further	NULL
confirmed	NULL
by	NULL
isolating	NULL
the	NULL
cells	NULL
sorted	NULL
by	NULL
flow	NULL
cytometry	NULL
.	NULL

T	NULL
cells	NULL
positively	NULL
stained	NULL
with	NULL
the	NULL
DQ0602/369-380	NULL
tetramer	NULL
were	NULL
FACS	NULL
sorted	NULL
and	NULL
cloned	NULL
at	NULL
3	NULL
cells/well	NULL
;	NULL
the	NULL
sorted	NULL
T	NULL
cells	NULL
were	NULL
then	NULL
expanded	NULL
by	NULL
PHA	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IL-2	NULL
to	NULL
generate	NULL
47	NULL
cell	NULL
lines	NULL
.	NULL

Staining	NULL
with	NULL
tetramers	NULL
and	NULL
proliferation	NULL
assays	NULL
with	NULL
the	NULL
369-380	NULL
peptide	NULL
are	NULL
summarized	NULL
in	NULL
Table	NULL
I.	NULL
Thirty-six	NULL
cell	NULL
lines	NULL
were	NULL
positive	NULL
for	NULL
the	NULL
staining	NULL
and	NULL
the	NULL
proliferation	NULL
as-says	NULL
;	NULL
11	NULL
lines	NULL
were	NULL
negative	NULL
for	NULL
both	NULL
staining	NULL
and	NULL
the	NULL
proliferation	NULL
assays	NULL
.	NULL

Thus	NULL
,	NULL
77	NULL
%	NULL
of	NULL
the	NULL
sorted	NULL
T	NULL
cells	NULL
were	NULL
specific	NULL
for	NULL
the	NULL
VP16	NULL
369-380	NULL
peptide	NULL
as	NULL
assayed	NULL
by	NULL
tetramer	NULL
staining	NULL
and	NULL
proliferation	NULL
,	NULL
compared	NULL
with	NULL
2-3	NULL
%	NULL
T	NULL
cells	NULL
staining	NULL
with	NULL
the	NULL
tetramer	NULL
in	NULL
the	NULL
original	NULL
unsorted	NULL
sample	NULL
.	NULL

This	NULL
confirms	NULL
the	NULL
Ag-specific	NULL
properties	NULL
of	NULL
peripheral	NULL
blood	NULL
T	NULL
cells	NULL
detected	NULL
using	NULL
tetramer	NULL
staining	NULL
.	NULL

The	NULL
less	NULL
then	NULL
perfect	NULL
correlation	NULL
between	NULL
the	NULL
sorted	NULL
cells	NULL
and	NULL
reactivity	NULL
to	NULL
the	NULL
VP16	NULL
peptide	NULL
was	NULL
probably	NULL
due	NULL
to	NULL
nonstringent	NULL
fluorometry	NULL
settings	NULL
for	NULL
the	NULL
T	NULL
cell	NULL
population	NULL
,	NULL
which	NULL
was	NULL
gated	NULL
for	NULL
1	NULL
%	NULL
positive	NULL
cells	NULL
.	NULL

The	NULL
overall	NULL
fluorescence	NULL
intensity	NULL
as	NULL
shown	NULL
in	NULL
Table	NULL
I	NULL
for	NULL
these	NULL
cell	NULL
lines	NULL
was	NULL
variable	NULL
,	NULL
due	NULL
to	NULL
heterogeneity	NULL
in	NULL
the	NULL
cell	NULL
population	NULL
.	NULL

There	NULL
was	NULL
no	NULL
correlation	NULL
between	NULL
the	NULL
extent	NULL
of	NULL
proliferation	NULL
and	NULL
the	NULL
intensity	NULL
of	NULL
the	NULL
fluorescence	NULL
signal	NULL
.	NULL

This	NULL
study	NULL
demonstrates	NULL
the	NULL
feasibility	NULL
of	NULL
using	NULL
MHC	NULL
class	NULL
II	NULL
tetramers	NULL
to	NULL
directly	NULL
visualize	NULL
a	NULL
small	NULL
cohort	NULL
of	NULL
Ag-specific	NULL
DQ-restricted	NULL
T	NULL
cells	NULL
from	NULL
peripheral	NULL
blood	NULL
.	NULL

A	NULL
broad	NULL
spectrum	NULL
of	NULL
class	NULL
II	NULL
tetrameric	NULL
complexes	NULL
can	NULL
potentially	NULL
be	NULL
generated	NULL
fairly	NULL
easily	NULL
by	NULL
loading	NULL
peptides	NULL
into	NULL
class	NULL
II	NULL
molecules	NULL
by	NULL
the	NULL
technique	NULL
illus-trated	NULL
.	NULL

In	NULL
this	NULL
regard	NULL
,	NULL
this	NULL
study	NULL
is	NULL
more	NULL
similar	NULL
to	NULL
previous	NULL
work	NULL
with	NULL
MHC	NULL
class	NULL
I	NULL
tetramers	NULL
,	NULL
which	NULL
are	NULL
conventionally	NULL
loaded	NULL
with	NULL
peptide	NULL
during	NULL
purification	NULL
and	NULL
refolding	NULL
,	NULL
and	NULL
distinct	NULL
from	NULL
studies	NULL
with	NULL
murine	NULL
class	NULL
II	NULL
tetramers	NULL
which	NULL
have	NULL
utilized	NULL
covalent	NULL
peptide	NULL
tethered	NULL
to	NULL
single	NULL
MHC	NULL
molecules	NULL
(	NULL
11	NULL
,	NULL
12	NULL
)	NULL
.	NULL

Using	NULL
specific	NULL
tetramer	NULL
detection	NULL
,	NULL
the	NULL
precursor	NULL
frequency	NULL
of	NULL
HSV-2-specific	NULL
,	NULL
DQ-restricted	NULL
T	NULL
cells	NULL
was	NULL
highest	NULL
for	NULL
the	NULL
VP16	NULL
369-380	NULL
epitope	NULL
compared	NULL
with	NULL
the	NULL
33-52	NULL
epitope	NULL
,	NULL
illustrating	NULL
the	NULL
importance	NULL
of	NULL
direct	NULL
measurement	NULL
of	NULL
Ag-specific	NULL
T	NULL
cells	NULL
compared	NULL
with	NULL
inferences	NULL
about	NULL
immunodominance	NULL
derived	NULL
solely	NULL
from	NULL
peptide-MHC	NULL
binding	NULL
studies	NULL
.	NULL

This	NULL
study	NULL
also	NULL
demonstrates	NULL
a	NULL
rapid	NULL
and	NULL
sensitive	NULL
approach	NULL
for	NULL
cloning	NULL
specific	NULL
T	NULL
cells	NULL
from	NULL
human	NULL
peripheral	NULL
blood	NULL
utilizing	NULL
FACS	NULL
sorting	NULL
of	NULL
tetramer-positive	NULL
cells	NULL
as	NULL
a	NULL
first	NULL
step	NULL
.	NULL

In	NULL
view	NULL
of	NULL
the	NULL
limited	NULL
data	NULL
on	NULL
DQ-restricted	NULL
T	NULL
cells	NULL
,	NULL
the	NULL
use	NULL
of	NULL
tetrameric	NULL
DQ	NULL
reagents	NULL
should	NULL
provide	NULL
valuable	NULL
insight	NULL
regarding	NULL
the	NULL
role	NULL
of	NULL
DQ-restricted	NULL
CD4	NULL
*	NULL
T	NULL
cells	NULL
in	NULL
both	NULL
abnormal	NULL
and	NULL
normal	NULL
immune	NULL
regulation	NULL
.	NULL

Acknowledgments	NULL
We	NULL
thank	NULL
Nicky	NULL
Ducommun	NULL
for	NULL
manuscript	NULL
preparation	NULL
.	NULL

References	NULL
1	NULL
.	NULL

Todd	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
J.	NULL
I	NULL
.	NULL

Bell	NULL
,	NULL
and	NULL
H.	NULL
O.	NULL
McDevitt	NULL
.	NULL

1987	NULL
.	NULL

HLA-DQB	NULL
gene	NULL
contributes	NULL
to	NULL
susceptibility	NULL
and	NULL
resistance	NULL
to	NULL
insulin-dependent	NULL
diabetes	NULL
mellitus	NULL
.	NULL

Nature	NULL
329	NULL
;	NULL
599	NULL
.	NULL

2	NULL
.	NULL

Sollid	NULL
,	NULL
L.	NULL
M.	NULL
,	NULL
G.	NULL
Markussen	NULL
,	NULL
J.	NULL
Ek	NULL
,	NULL
H.	NULL
Gjerde	NULL
,	NULL
F.	NULL
Vartdal	NULL
,	NULL
and	NULL
E.	NULL
Thorsby	NULL
.	NULL

1989	NULL
.	NULL

Evidence	NULL
for	NULL
a	NULL
primary	NULL
association	NULL
of	NULL
celiac	NULL
disease	NULL
to	NULL
a	NULL
particular	NULL
HLA-DQ	NULL
a/f	NULL
heterodimer	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

169:345	NULL
.	NULL

3	NULL
.	NULL

Scharf	NULL
,	NULL
S.	NULL
J.	NULL
,	NULL
A.	NULL
Freidmann	NULL
,	NULL
L.	NULL
Steinman	NULL
,	NULL
C.	NULL
Brautbar	NULL
,	NULL
and	NULL
H.	NULL
A.	NULL
Erlich	NULL
.	NULL

1989	NULL
.	NULL

Specific	NULL
HLA-DQB	NULL
and	NULL
HLA-DRB1	NULL
alleles	NULL
confer	NULL
susceptibility	NULL
to	NULL
pemphigus	NULL
vulgaris	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
86:6215	NULL
.	NULL

4	NULL
.	NULL

Badenhoop	NULL
,	NULL
K.	NULL
,	NULL
P.	NULL
G.	NULL
Walfish	NULL
,	NULL
H.	NULL
Rau	NULL
,	NULL
S.	NULL
Fischer	NULL
,	NULL
A.	NULL
Nicolay	NULL
,	NULL
U.	NULL
Bogner	NULL
,	NULL
H.	NULL
Schleusener	NULL
,	NULL
and	NULL
K.	NULL
H.	NULL
Usadel	NULL
.	NULL

1995	NULL
.	NULL

Susceptibility	NULL
and	NULL
resistance	NULL
alleles	NULL
of	NULL
human	NULL
leukocyte	NULL
antigen	NULL
(	NULL
HLA	NULL
)	NULL
DQA1	NULL
and	NULL
HLA	NULL
DQB1	NULL
are	NULL
shared	NULL
in	NULL
endocrine	NULL
autoimmune	NULL
disease	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Endocrinol	NULL
.	NULL

Metab	NULL
.	NULL

80:2112	NULL
.	NULL

5	NULL
.	NULL

Altman	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
P.	NULL
A.	NULL
H.	NULL
Moss	NULL
,	NULL
P.	NULL
J.	NULL
R.	NULL
Goulder	NULL
,	NULL
D.	NULL
H.	NULL
Barouch	NULL
,	NULL
M.	NULL
G.	NULL
McHeyzer-Williams	NULL
,	NULL
J.	NULL
I	NULL
.	NULL

Bell	NULL
,	NULL
A.	NULL
J.	NULL
McMichael	NULL
,	NULL
and	NULL
M.	NULL
M.	NULL
Davis	NULL
.	NULL

1996	NULL
.	NULL

Phenotypic	NULL
analysis	NULL
of	NULL
antigen-specific	NULL
T	NULL
lymphocytes	NULL
.	NULL

Science	NULL
274:94	NULL
.	NULL

6	NULL
.	NULL

Callan	NULL
,	NULL
M.	NULL
F.	NULL
,	NULL
L.	NULL
Tan	NULL
,	NULL
N.	NULL
Annels	NULL
,	NULL
G.	NULL
S.	NULL
Ogg	NULL
,	NULL
J.	NULL
D.	NULL
Wilson	NULL
,	NULL
C.	NULL
A.	NULL
O'Callaghan	NULL
,	NULL
N.	NULL
Steven	NULL
,	NULL
A.	NULL
J.	NULL
McMichael	NULL
,	NULL
and	NULL
A	NULL
.	NULL

B.	NULL
Rickinson	NULL
.	NULL

1998	NULL
.	NULL

Direct	NULL
visualization	NULL
of	NULL
6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
10	NULL
.	NULL

11	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15.	NULL
antigen-specific	NULL
CD8	NULL
*	NULL
T	NULL
cells	NULL
during	NULL
the	NULL
primary	NULL
immune	NULL
response	NULL
to	NULL
Epstein-Barr	NULL
virus	NULL
in	NULL
vivo	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

187:1395.	NULL
.	NULL

Wilson	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
G.	NULL
S.	NULL
Ogg	NULL
,	NULL
R.	NULL
L.	NULL
Allen	NULL
,	NULL
P.	NULL
J.	NULL
Goulder	NULL
,	NULL
A.	NULL
Kelleher	NULL
,	NULL
A.	NULL
K.	NULL
Sewell	NULL
,	NULL
C.	NULL
A.	NULL
O'Callaghan	NULL
,	NULL
S.	NULL
L.	NULL
Rowland-Jones	NULL
,	NULL
M.	NULL
F.	NULL
Callan	NULL
,	NULL
and	NULL
A.	NULL
J.	NULL
McMichael	NULL
.	NULL

1998	NULL
.	NULL

Oligoclonal	NULL
expansions	NULL
of	NULL
CD8	NULL
(	NULL
+	NULL
)	NULL
T	NULL
cells	NULL
in	NULL
chronic	NULL
HIV	NULL
infection	NULL
are	NULL
antigen	NULL
specific	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

188:785.	NULL
.	NULL

Gallimore	NULL
,	NULL
A.	NULL
,	NULL
A.	NULL
Glithero	NULL
,	NULL
A.	NULL
Godkin	NULL
,	NULL
A.	NULL
C.	NULL
Tissot	NULL
,	NULL
A.	NULL
Pluckthun	NULL
,	NULL
T.	NULL
Elliott	NULL
,	NULL
H.	NULL
Hengartner	NULL
,	NULL
and	NULL
R.	NULL
Zinkernagel	NULL
.	NULL

1998	NULL
.	NULL

Induction	NULL
and	NULL
exhaustion	NULL
of	NULL
lympho-cytic	NULL
choriomeningitis	NULL
virus-specific	NULL
cytotoxic	NULL
T	NULL
lymphocytes	NULL
visualized	NULL
using	NULL
soluble	NULL
tetrameric	NULL
major	NULL
histocompatibility	NULL
complex	NULL
class	NULL
I-peptide	NULL
complexes	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

187:1383.	NULL
.	NULL

Yee	NULL
,	NULL
C.	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

Savage	NULL
,	NULL
P.	NULL
P.	NULL
Lee	NULL
,	NULL
M.	NULL
M.	NULL
Davis	NULL
,	NULL
and	NULL
P.	NULL
D.	NULL
Greenberg	NULL
.	NULL

1999	NULL
.	NULL

Isolation	NULL
of	NULL
high	NULL
avidity	NULL
melanoma-reactive	NULL
CTL	NULL
from	NULL
heterogencous	NULL
populations	NULL
using	NULL
peptide-MHC	NULL
tetramers	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

162:2227	NULL
.	NULL

Lee	NULL
,	NULL
P.	NULL
P.	NULL
,	NULL
C.	NULL
Yee	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

Savage	NULL
,	NULL
L.	NULL
Fong	NULL
,	NULL
D.	NULL
Brockstedt	NULL
,	NULL
J.	NULL
S.	NULL
Weber	NULL
,	NULL
D.	NULL
Johnson	NULL
,	NULL
S.	NULL
Swetter	NULL
,	NULL
J.	NULL
Thompson	NULL
,	NULL
P.	NULL
D.	NULL
Greenberg	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1999	NULL
.	NULL

Characterization	NULL
of	NULL
circulating	NULL
T	NULL
cells	NULL
specific	NULL
for	NULL
tumor-associated	NULL
antigens	NULL
in	NULL
melanoma	NULL
patients	NULL
.	NULL

Nat	NULL
.	NULL

Med	NULL
.	NULL

5:277	NULL
.	NULL

Crawford	NULL
,	NULL
F.	NULL
,	NULL
H.	NULL
Kozono	NULL
,	NULL
J	NULL
.	NULL

White	NULL
,	NULL
P.	NULL
Marrack	NULL
,	NULL
and	NULL
J.	NULL
Kappler	NULL
.	NULL

1998	NULL
.	NULL

Detection	NULL
of	NULL
antigen-specific	NULL
T	NULL
cells	NULL
with	NULL
multivalent	NULL
soluble	NULL
class	NULL
II	NULL
MHC	NULL
covalent	NULL
peptide	NULL
complexes	NULL
.	NULL

Immunity	NULL
8:675	NULL
.	NULL

Rees	NULL
,	NULL
W.	NULL
,	NULL
J.	NULL
Bender	NULL
,	NULL
T.	NULL
K.	NULL
Teague	NULL
,	NULL
R.	NULL
M.	NULL
Kedl	NULL
,	NULL
F.	NULL
Crawford	NULL
,	NULL
P.	NULL
Marrack	NULL
,	NULL
and	NULL
J.	NULL
Kappler	NULL
.	NULL

1999	NULL
.	NULL

An	NULL
inverse	NULL
relationship	NULL
between	NULL
T	NULL
cell	NULL
receptor	NULL
affinity	NULL
and	NULL
antigen	NULL
dose	NULL
during	NULL
CD4*	NULL
T	NULL
cell	NULL
responses	NULL
in	NULL
vivo	NULL
and	NULL
in	NULL
vitro	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
96:9781	NULL
.	NULL

Savage	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
J.	NULL
J.	NULL
Boniface	NULL
,	NULL
and	NULL
M.	NULL
M.	NULL
Davis	NULL
.	NULL

1999	NULL
.	NULL

A	NULL
kinetic	NULL
basis	NULL
for	NULL
T	NULL
cell	NULL
receptor	NULL
repertoire	NULL
selection	NULL
during	NULL
an	NULL
immune	NULL
response	NULL
.	NULL

Immunity	NULL
10:485	NULL
.	NULL

Novak	NULL
,	NULL
E.	NULL
J.	NULL
,	NULL
A.	NULL
W.	NULL
Liu	NULL
,	NULL
G.	NULL
T.	NULL
Nepom	NULL
,	NULL
and	NULL
W.	NULL
W.	NULL
Kwok	NULL
.	NULL

1999	NULL
.	NULL

Peptide-specific	NULL
human	NULL
CD4*	NULL
T	NULL
cells	NULL
proliferating	NULL
in	NULL
response	NULL
to	NULL
influenza	NULL
A	NULL
antigen	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

104	NULL
:	NULL
R63	NULL
.	NULL

Reizis	NULL
,	NULL
B.	NULL
,	NULL
D.	NULL
M.	NULL
Altmann	NULL
,	NULL
and	NULL
I.	NULL
R.	NULL
Cohen	NULL
.	NULL

1997	NULL
.	NULL

Biochemical	NULL
characterization	NULL
of	NULL
the	NULL
human	NULL
diabetes-associated	NULL
HLA-DQ8	NULL
allelic	NULL
product	NULL
:	NULL
similarity	NULL
to	NULL
the	NULL
16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

4249	NULL
major	NULL
histocompatibility	NULL
complex	NULL
class	NULL
II	NULL
I-A*	NULL
``	NULL
protein	NULL
of	NULL
non-obese	NULL
diabetic	NULL
mice	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

27:2478	NULL
.	NULL

Ettinger	NULL
,	NULL
R.	NULL
A.	NULL
,	NULL
A.	NULL
W.	NULL
Liu	NULL
,	NULL
G.	NULL
T.	NULL
Nepom	NULL
,	NULL
and	NULL
W.	NULL
W.	NULL
Kwok	NULL
.	NULL

1999	NULL
.	NULL

Exceptional	NULL
stability	NULL
of	NULL
the	NULL
HLA-DQA1*0102/DQB1*0602	NULL
B	NULL
protein	NULL
dimer	NULL
,	NULL
the	NULL
class	NULL
II	NULL
MHC	NULL
molecule	NULL
associated	NULL
with	NULL
protection	NULL
from	NULL
insulin-dependent	NULL
diabetes	NULL
mellitus	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

161:6439	NULL
.	NULL

Ashley	NULL
,	NULL
R.	NULL
A.	NULL
,	NULL
J.	NULL
Militoni	NULL
,	NULL
F.	NULL
Lee	NULL
,	NULL
A.	NULL
Nahmias	NULL
,	NULL
and	NULL
L.	NULL
Corey	NULL
.	NULL

1988	NULL
.	NULL

Comparison	NULL
of	NULL
Western	NULL
blot	NULL
(	NULL
immunoblot	NULL
)	NULL
and	NULL
glycoprotein	NULL
G-specific	NULL
immunoblot	NULL
for	NULL
detecting	NULL
antibodies	NULL
to	NULL
herpes	NULL
simplex	NULL
types	NULL
1	NULL
and	NULL
2	NULL
in	NULL
human	NULL
sera	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Mi-crobiol	NULL
.	NULL

26:662	NULL
.	NULL

Mickelson	NULL
,	NULL
E.	NULL
,	NULL
A.	NULL
Smith	NULL
,	NULL
S.	NULL
McKinney	NULL
,	NULL
G.	NULL
Anderson	NULL
,	NULL
and	NULL
J	NULL
.	NULL

A.	NULL
Hansen	NULL
.	NULL

1993	NULL
.	NULL

A	NULL
comparative	NULL
study	NULL
of	NULL
HLA-DRB1	NULL
typing	NULL
by	NULL
standard	NULL
serology	NULL
and	NULL
hybridization	NULL
of	NULL
non-radioactive	NULL
sequence-specific	NULL
oligonucleotide	NULL
probes	NULL
to	NULL
PCR-amplified	NULL
DNA	NULL
.	NULL

Tissue	NULL
Antigens	NULL
41:86	NULL
.	NULL

Horton	NULL
,	NULL
R.	NULL
M.	NULL
,	NULL
Z.	NULL
L.	NULL
Cai	NULL
,	NULL
S.	NULL
N.	NULL
Ho	NULL
,	NULL
and	NULL
L.	NULL
R.	NULL
Pease	NULL
.	NULL

1990	NULL
.	NULL

Gene	NULL
splicing	NULL
by	NULL
overlap	NULL
extension	NULL
:	NULL
tailor-made	NULL
genes	NULL
using	NULL
the	NULL
polymerase	NULL
chain	NULL
reaction	NULL
.	NULL

Bio-Techniques	NULL
8:528	NULL
.	NULL

Ettinger	NULL
,	NULL
R.	NULL
A.	NULL
,	NULL
and	NULL
W.	NULL
W.	NULL
Kwok	NULL
.	NULL

1998	NULL
.	NULL

A	NULL
peptide	NULL
binding	NULL
motif	NULL
for	NULL
HLA-DQA1*0102/DQB1*0602	NULL
,	NULL
the	NULL
class	NULL
II	NULL
MHC	NULL
molecule	NULL
associated	NULL
with	NULL
dominant	NULL
protection	NULL
in	NULL
insulin-dependent	NULL
diabetes	NULL
mellitus	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

160:2365	NULL
.	NULL

Genevée	NULL
,	NULL
C.	NULL
,	NULL
A.	NULL
Diu	NULL
,	NULL
J.	NULL
Nierat	NULL
,	NULL
A.	NULL
Caignard	NULL
,	NULL
P.-Y	NULL
.	NULL

Dietrich	NULL
,	NULL
L.	NULL
Ferradini	NULL
,	NULL
S.	NULL
Roman-Roman	NULL
,	NULL
F.	NULL
Triebel	NULL
,	NULL
and	NULL
T.	NULL
Hercend	NULL
.	NULL

1992	NULL
.	NULL

An	NULL
experimentally	NULL
validated	NULL
panel	NULL
of	NULL
subfamily-specific	NULL
oligonucleotide	NULL
primers	NULL
(	NULL
Val-w29/VB1-w24	NULL
)	NULL
for	NULL
the	NULL
study	NULL
of	NULL
human	NULL
T	NULL
cell	NULL
receptor	NULL
variable	NULL
V	NULL
gene	NULL
segment	NULL
usage	NULL
by	NULL
polymerase	NULL
chain	NULL
reaction	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

22:1261	NULL
.	NULL

Koelle	NULL
,	NULL
D.	NULL
M.	NULL
,	NULL
J.	NULL
M.	NULL
Frank	NULL
,	NULL
M.	NULL
L.	NULL
Johnson	NULL
,	NULL
and	NULL
W.	NULL
W.	NULL
Kwok	NULL
.	NULL

1998	NULL
.	NULL

Recognition	NULL
of	NULL
herpes	NULL
simplex	NULL
virus	NULL
type	NULL
2	NULL
tegument	NULL
proteins	NULL
by	NULL
CD4	NULL
T	NULL
cells	NULL
infiltrating	NULL
human	NULL
genital	NULL
herpes	NULL
lesions	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

72:7476	NULL
.	NULL

Liu	NULL
,	NULL
Y.	NULL
,	NULL
W.	NULL
Gong	NULL
,	NULL
C.	NULL
C.	NULL
Huang	NULL
,	NULL
W.	NULL
Herr	NULL
,	NULL
and	NULL
X.	NULL
Cheng	NULL
.	NULL

1999	NULL
.	NULL

Crystal	NULL
structure	NULL
of	NULL
the	NULL
conserved	NULL
core	NULL
of	NULL
the	NULL
herpes	NULL
simplex	NULL
virus	NULL
transcriptional	NULL
regulatory	NULL
protein	NULL
VP16	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

13:1692	NULL
.	NULL

6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL

